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ABSTRACT 
 
DAVID L. ROSEN: Factors associated with voluntary HIV testing and serostatus among  
North Carolina state prisoners, 2004-2006 
(Under the direction of Victor J. Schoenbach) 
Background. Despite the heavy burden of HIV among prisoners, HIV testing strategies vary 
widely across US state prison systems.  A voluntary HIV testing program in a large southern 
state prison system was evaluated by estimating HIV testing rates among prisoners, 
identifying inmate characteristics associated with testing status and infection status, and 
estimating the number of infected prisoners who remained untested during their 
incarceration.   
Methods.  Electronic imprisonment and lab records were obtained for all prisoners entering 
the NC DOC between January 2004 and May 2006.  Associations between inmate 
characteristics and both HIV testing and HIV serostatus were estimated separately using log-
linear and logistic regression.  The number of undetected cases was estimated using age-sex-
race specific HIV prevalences from tested prisoners and from statewide HIV reporting. 
Results.  Eight-five percent of female and 31% of male prisoners were tested for HIV during 
their incarceration.  In four of the six intake prisons for men, <15% of prisoners were tested.  
Among men, the proportion tested was 10% higher among those reporting heroin use, 
crack/cocaine use, tuberculosis disease, and any conventional HIV risk behavior (e.g. sharing 
needles, MSM), but >60% of men reporting a conventional risk behavior remained untested. 
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In bivariate and covariate-adjusted analyses, black men were 30% and 13%, respectively, 
less likely than whites to be tested.  
Nearly 3.4% (718/21,419) of tested prisoners were HIV+. Of those HIV+ prisoners, 
<50% reported a history of any conventional HIV risk behaviors.  Infection was most 
strongly associated with being a MSM (OR=8.0), non-white race (OR=6.2-7.4), and ages 35-
44 years (OR=4.1).   The strongest risk factor among women was black race (OR=3.8); ORs 
< 3.0 were observed for several other risk factors.  Sixty-five percent of HIV+ prisoners were 
HCV-coinfected.  Between 23% and 63% of HIV cases remained undetected.   
Conclusion.  HIV testing varied greatly by intake prison, and many male inmates were never 
tested.  The majority of cases denied conventional HIV risk behaviors suggesting limitations 
of risk-factor based testing.  Expanded HIV testing could improve case finding.  However, 
testing expansion must be joined with adequate treatment and follow-up services, and 
monitoring is needed to ensure testing is not coercive. 
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CHAPTER 1 
INTRODUCTION 
In June, 1981, the Centers for Disease Control and Prevention (CDC) published a 
report of “5 young men, all active homosexuals” who had laboratory confirmed 
Pneumocystis carinii pneumonia.1, 2  The editorial accompanying the report concluded that 
the cases “suggested the possibility of a cellular-immune dysfunction related to a common 
exposure that predisposes individuals to opportunistic infections.” 1, 2  During the next two 
years, the wide range of sequelae resulting from the cellular-immune dysfunction referred to 
in the editorial would be named Acquired Immune Deficiency Syndrome (AIDS), and its 
causative pathogen identified as the Human Immunodeficiency Virus (HIV).   
By the mid 1980’s, the annual number of new HIV infections in the US reached 
150,000 and the number of deaths was ever-increasing.3  But a combination of public 
awareness, public health prevention programs, and the eventual development of treatment 
reduced both the spread and the toll of AIDS domestically.  By the mid 1990’s, the number 
of new AIDS cases and AIDS deaths began to dramatically decline.3  Despite these declines, 
the number of new HIV infections has remained essentially stable at an estimated 40,000 
annual cases for the last 15 years.4     
At the same time, the face of HIV/AIDS has changed.  Initially seen as a gay white 
man’s disease, by the 1990s HIV/AIDS was disproportionately prevalent among poor
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minority communities including women.  Despite comprising just 13% of the US population, 
by 1996 blacks accounted for more new cases of HIV than any other racial/ethnic group.3    
As HIV was becoming increasingly prevalent among minority communities, these 
same communities were being disproportionately affected by incarceration.  Starting in the 
late 1970s and continuing through the 1980s and 1990s, the prison population increased 
nearly 3-fold, a result of harsher sentences with less flexibility for early release and an 
increase in the imprisonment rate among arrestees.5  Although both blacks and whites 
experienced large relative increases in imprisonment, the absolute increase among blacks 
greatly outpaced that of whites.  From 1974 to 2001, the proportion of US residents ever 
imprisoned rose from 1.4% to 2.6% among whites and from 6.7% to 16.6% among blacks,6 
so that today the US has the highest imprisonment rate in the world.7   
With overlap between behaviors that increase risk for both HIV infection and arrest, 
and overrepresentation of minority communities with relatively high rates of HIV infection, 
prisons have become an important venue to identify new HIV cases.  But in the absence of 
federal regulations, HIV testing policies differ across US state prison systems.   
As of 2005, 22 state prison systems mandated HIV testing for all inmates.8  In the 
other 27 state prison systems with available data, voluntary (i.e. consent-based) testing is 
performed.  Little is known, however, about the extent of use or effectiveness of voluntary 
HIV testing in prison.  In light of the 2006 CDC recommendations to expand HIV testing in 
the US across venues, including correctional settings, this dissertation assesses the use of 
voluntary HIV testing services in a large southern prison system, the North Carolina 
Department of Correction (NC DOC).  Specific aims of this project are the following:  
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Specific Aim 1. Determine system-wide and facility-specific HIV testing rates among 
inmates without a pre-existing HIV diagnosis, in a state prison system with voluntary HIV 
testing 
Specific Aim 2.  Identify inmate characteristics associated with receipt of an HIV test among 
inmates without a pre-existing HIV diagnosis  
Specific Aim 3. Identify inmate characteristics associated with HIV serostatus  
Specific Aim 4. Estimate the number of HIV-infected prisoners who remain untested in the 
North Carolina prison system 
 
Chapters 2 and 3 provide a review of issues relevant to HIV testing services in prison.  
Chapters 5 and 6, which were written as stand-alone manuscripts, present the results of 
analyses addressing specific aims one through four.  Chapter seven provides a synthesis of 
results and discussion from chapters 5 and 6, presents policy recommendations, and outlines 
future areas of inquiry.    
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
BACKGROUND AND SIGNIFICANCE 
.   At mid-year 2003 US state prisons incarcerated approximately 1.2 million 
individuals,9 a population that has grown by 270% since 1985.10   The majority of those 
incarcerated are impoverished young men of color9 with low levels of educational 
achievement11 and little contact with health care services.12, 13  In the community, these men 
have high rates of communicable diseases.13  Since there is some commonality between illicit 
behaviors and behaviors that put one at risk for communicable disease, the burden of 
communicable diseases tends to be disproportionately high in prison populations as 
compared to community populations.  
 HIV has taken a particularly high toll on the health of incarcerated populations.  The 
prevalence of HIV among state prison inmates is estimated to be 2.3-2.98%, a range 
approximately 8-10 times that of non-incarcerated populations (0.3%).14  With 13-19% of all 
those infected with HIV thought to be released from a prison or jail each year, 14 these 
facilities provide an important opportunity to test high risk populations.15  HIV screening in 
prison has been endorsed by the Centers for Disease Control and Prevention as a key strategy 
in the control of the US HIV epidemics.16  
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There are several individual and societal benefits of HIV testing.   
Inmates tested for HIV in prison are more likely to receive their results than if tested in the 
community.   
In community settings, HIV testing services are limited by clients’ willingness to 
return for results.  A multi-city study of high-risk individuals conducted as part of the CDC’s 
HIV Testing Survey (HITS) found that 10- 27% of respondents failed to return for test 
results, and those with the highest self-perception of risk for infection were least likely to 
return.17  Greater than half (55%) of clients attending public testing sites in one southern state 
did not return for their results and 7 HIV-infected individuals were never located.18  Given 
these high rates of failure to return, it is not surprising that receipt of results is higher among 
incarcerated testers than testers in other settings (CDC unpublished data, cited in 19). 
   
HIV-positive inmates can matriculate into medical care and access ancillary services.   
Once detected, infected inmates can initiate medical treatment at no monetary cost to 
themselves; access to antiretroviral care is a constitutionally protected right (8th 
Amendment), confirmed by the courts.14  HIV treatment can suppress viral burden resulting 
in reconstitution of the immune system, reduction in opportunistic infections, and reduction 
of transmission risk.  HIV care in prisons has generally been successful as demonstrated by a 
75% decline in AIDS-related deaths among state prisoners from 1995 to 2001,20 a reduction 
comparable to national trends among non-incarcerated populations.21  Two studies 
supporting the benefits of HIV care in prison report that recidivists have greater levels of 
viral suppression while incarcerated than in the community.22, 23  In addition to medical 
services, the widespread availability of substance abuse treatment programs and mental 
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health services available in prison may provide psychosocial support to inmates as they deal 
with the emotional, social and psychological consequences (e.g. depression and adjustment 
disorder) commonly associated with newly detected infection.   
Diagnosed inmates may reduce their risk behaviors as they return to their communities.   
With counseling and testing shown to reduce sexual risk behaviors among individuals 
testing seropositive,24-26 inmates testing positive for HIV while in prison may reduce the 
frequency of their high risk behaviors upon release, as compared to pre-incarceration levels.  
As a result, HIV testing in prison may help reduce community rates of HIV transmission.  
Studies conducted among Rhode Island and Massachusetts inmates have shown that services 
which support continuity of care as HIV-infected inmates return to their communities have 
the additional benefit of reducing recidivism among this population.27, 28  These reductions 
may be indicative of reduced risk behaviors in the community.     
 
Most prison inmates are incarcerated in facilities with voluntary HIV testing; large 
variations in testing rates exist between state systems.   
As of 2005, 22 state prison systems had a policy of mandatory HIV testing upon 
prison admission.  Of the other 27 prison systems without a policy of mandatory testing upon 
inmate admission (data was unavailable for Alaska), all systems reported testing upon inmate 
request, 7 reported targeted testing of high risk groups, and 26 reported testing upon clinical 
indication.29  All of these testing scenarios require inmate consent, and as such, are 
collectively referred to as voluntary testing.30  Our calculations indicate that greater than 50% 
of all prison inmates are incarcerated in prison systems with a policy of voluntary testing, and 
data from existing studies suggest that HIV testing in these prison systems ranges widely 
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(39%-71%).31, 32  These observed testing rates, however, may not be representative of 
nationwide testing.   
Despite the large number of inmates incarcerated in facilities with voluntary testing 
and the wide range of testing rates from existing studies, few studies have examined 
individual and systemic factors related to inmates’ receipt of HIV testing.  Information from 
such an evaluation could be useful in improving voluntary testing programs.   
HIV testing is likely to remain consent-based within the majority of prison systems.  
The proportion of prison systems with voluntary HIV testing has remained relatively stable 
since at least 199333, 34, suggesting that a policy of voluntary testing is firmly entrenched in 
many prison systems.  The continued implementation of voluntary testing is firmly supported 
by the American Public Health Association, and the World Health Organization Programme 
on AIDS considers mandatory testing unethical and a violation of basic human rights35, 36.  
Despite some experts’ argument that mandatory testing, conducted in a non-prejudicial 
manner, is an effective and appropriate policy to detect HIV infection,15 there is little 
evidence to suggest future policy changes.  As such, the evaluation of voluntary HIV testing 
among inmates is, and will likely remain, a relevant public health issue.    
 
Seroprevalence studies indicate a substantial proportion of infected inmates remain 
undetected in prison systems with voluntary testing.   
Seroprevalence studies that include information about inmate testing decisions 
provide a powerful tool to evaluate the effectiveness of voluntary testing services.  Rates of 
HIV infection observed in seroprevalence studies exceeded rates of infection observed from 
voluntary testing alone in the Maryland, California, Illinois, New Jersey,30 Wisconsin37 and 
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Oregon38 state prison systems.  Studies in the Maryland (1994)39 and Wisconsin (1998)37 
state prison systems, for example, reported that rates of HIV-infection among those tested 
blindly were twice that of volunteer testers.  In Wisconsin, 31% (8/26) of all HIV-infected 
inmates declined to be tested, and in Maryland 66% (134/204) of all HIV-infected inmates 
declined testing, suggesting that an important proportion of HIV-infected inmates remain 
undetected in prison systems with volunteer testing policies. While some HIV-infected 
inmates in these studies may have opted out of testing because they were already aware of 
their serostatus, no documentation exists to substantiate this possibility.   
 
Overlap exists between inmate characteristics associated with both HIV infection and 
decreased acceptance of testing.   
Four US seroprevalence studies reporting inmate characteristics and HIV infection 
status have been published in the last 15 years.  Inmate characteristics associated with HIV-
infection in these studies include female gender39, 40, African American37, 39, 41 and Hispanic32 
race-ethnicities, increasing age,37, 39, 41 increasing number of prior incarcerations,32 shorter 
sentence length,39 history of sexually transmitted disease,39, 41 history of injection drug use,39, 
41
 Hepatitis B seropositivity,37 and history of a psychiatric condition.41    
Three US studies and one Canadian study have examined the relationship between 
inmate characteristics and acceptability of testing. The Maryland study (1994) found inmates 
40 years of age or older, drug offenders, and African Americans were reported to be more 
likely to refuse voluntary HIV testing than other inmates.39  Inmates with hepatitis B 
seromarkers37 and female inmates with a history of drug-related convictions or exchanging 
sex for money or drugs42 have also been shown to have lower acceptance rates of HIV tests 
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compared with other inmates.  A more recent study of Ontario inmates by Burchell et al 
found that testing was positively associated with injection drug use but negatively associated 
with report of “casual” community partners.43   
In total, the overlap of characteristics associated with both HIV infection and 
decreased acceptance of testing is cause for great concern and supports the need for research 
investigating reasons why high risk inmates opt out of voluntary HIV testing. 
Although few studies have been conducted examining HIV testing among prisoners, 
reasons informing testing decisions have been examined among other high risk populations.  
The CDC’s HITS is a serial, multi-city study of HIV testing decisions among individuals at 
high risk for HIV; respondents were recruited through STD clinics, street outreach, and gay 
bars.44  The first two waves, HITS-I and HITS-II, were conducted during 1995-1996 and 
1998-1999, respectively.  Statements most frequently endorsed by respondents tested for 
HIV were "to know where you stood” (HITS-I 41%, HITS-II 45%) and "thought exposed 
during sex" (HITS-I 12%, HITS-II 14%), suggesting that testing behavior was encouraged as 
a means to assess health status and by perception of risk.  Among respondents not tested for 
HIV, “fear of a positive result” was most commonly cited in both surveys, but decreased 
from 27% to 18%, perhaps indicating a change of attitudes with the availability of highly 
active antiretroviral therapies (HAART).  
Considering that the only US study of inmate attitudes was conducted in 1991, studies 
are needed to assess if similar attitude changes have occurred among the incarcerated 
population.   Finally, while the HITS studies report broad reasons for testing decisions (e.g. 
there may exist many reasons to fear a positive HIV test), further investigations are necessary 
to elucidate the psychosocial factors shaping these reasons and ultimately, testing behaviors.   
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HIV testing in North Carolina 
In North Carolina, the state department of health collects data on HIV testing 
performed by county health departments as well as testing conducted by “a number of 
community-based organizations.”45  In 2004, the last year with available data, approximately 
120,000 HIV tests were reported to the state health department.  Of these tests, 36% were 
among people who had never previously been tested for HIV.  The proportion of tests 
positive for HIV was 0.2%.  The majority of tests, 92%, are conducted in traditional testing 
sites, such as public health departments. At traditional sites, the majority of clients receiving 
tests are women (68%), while the majority of tests at non-traditional sites are conducted 
among men (58%).  Overall, two-thirds of all tests are conducted among women.45      
 
HIV cases in the United States   
In the US, case data are available from the 33 states with confidential name-based 
HIV test reporting.  In these states, 76% of cases were among men, and 70% of cases were 
aged 25-49 years at the time of diagnosis.  About 50% of cases were among non-Hispanic 
blacks and 31% of cases were among non-Hispanic whites.  Among males, 67% of cases 
were attributed to male-to-male sexual contact, 13% were attributed to injection drug use, 
and another 5% were attributed to both MSM and injection drug use.  About 16% of cases 
were attributed to high risk heterosexual sexual contact.  Among women, 80% of cases were 
attributed to high risk sexual contact, and 19% attributed to injection drug use.46 
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HIV cases in North Carolina 
At the end of 2006, there were an estimated 31,000 people in North Carolina living 
with HIV.  Seventy percent of living HIV cases were among blacks, and 25% of cases were 
among whites.  Sixty-nine percent of living cases were male.  The HIV rate among black 
males (103/100,000) was greater than 7 times that of white males (14/100,000), and the HIV 
rate among black females (42/100,000) was nearly 17 times that of white females.  Among 
males, at least 46% of HIV transmission was thought to be from sex with other men while as 
much as 90% of transmission among women was from heterosexual contact.  Between 2-4% 
of men and 5-11% of women were infected via injection drug use.45 
 
In 2006 CDC updated its HIV testing recommendations, calling for routine opt-out testing 
across several health care venues, including correctional facilities.   
The CDC first developed its HIV testing recommendations in the mid-1980s, when 
treatment options were limited to prevention of a few opportunistic infections, and the fear of 
AIDS created an atmosphere of great stigma and severe discrimination for those infected.  
The early recommendations called for informed consent to help ensure that patients 
understood the testing process.  Pre- and post-test counseling was also regarded as essential 
so that patients would receive adequate guidance and emotional support.  Eventually, 
however, the use of written consent and pre-test counseling was thought to discourage 
healthcare providers from offering and patients from accepting HIV testing.   
With stunted progress in reducing new infections and the development of life-
extending treatment options, the CDC began exploring ways to improve testing uptake.  In 
2003, CDC updated its recommendations, calling for routine testing in settings in which the 
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prevalence of HIV was 1% or greater.4   That same year, CDC recommended that HIV 
testing be offered to prisoners upon intake, without prescribing a prevalence threshold.47   
In 2006 CDC released HIV testing recommendations in healthcare settings, including 
correctional facilities, calling for routine “opt-out testing” of persons aged 13-65 years 
regardless of setting prevalence.  CDC defined routine opt-out testing as the provision of 
testing as a regular part of medical care; patients are informed that they will be tested for 
HIV unless they actively decline.   Pre-test counseling and written consent are no longer 
required, but patients testing positive are still provided post-test counseling and referral to 
treatment.   
It is unclear whether these recommendations, which are specific to healthcare 
settings, are applicable to the testing of prisoners upon intake.   With concerns about the 
financial burden of increased testing as well as existing state laws which mandate that pre-
test counseling be provided before HIV testing is conducted, states have been slow to 
implement the 2006 recommendations in community settings.  Nevertheless, as routine opt-
out testing becomes increasingly common in community settings, state prison systems will 
likely face greater pressure to adopt similar testing policies.   
 
Health screening and processing of new inmates in the North Carolina prison system 
includes opportunity for HIV testing.   
Eight NC state prisons function as diagnostic processing centers, serving as entry 
points into the state prison system.  At these processing centers, inmate demographic, 
familial, and criminal histories are collected and entered into a computer database.  
Diagnostic tests are administered to inmates in groups to assess inmate education, reading 
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level, and skills. Inmates are also assessed for medical, dental, and mental health problems.  
As part of the medical assessment, inmates are queried about HIV-risk factors and are 
suppose to have an opportunity to be tested for HIV.  The mental health assessment begins 
with a 10 question screening form.  Affirmative responses, history of psychological 
problems, or any indication of psychological morbidity leads to a referral for further 
psychological evaluation for the purposes of diagnosis and treatment.   
 
Potential benefits of the proposed research to subjects and society. 
Results from this project will serve to improve our understanding of HIV testing at 
both the systemic- and individual-level.  This information will serve to improve testing 
uptake for the purpose of detecting more HIV infected inmates in the context of consent-
dependent testing.  The detection of infected inmates upon admission to prison is an 
important mechanism to matriculate inmates into medical care and to initiate antiretroviral 
therapies, when appropriate. As individuals continue antiretroviral therapy, viral burden, and 
consequently infectiousness, is dramatically reduced, reducing the probability of secondary 
transmission. Further, studies have shown that individuals who test positive for HIV 
subsequently reduce their HIV-related risk behaviors.  Given the substantial flow of people 
between prison and the community, the detection of HIV among prisoners could diminish 
secondary transmission upon inmates’ release.   
 The methods proposed in this dissertation to (1) assess system-wide HIV testing (2) 
identify individual characteristics associated with HIV testing and serostatus, and (3) 
estimate the number of undetected HIV-positive inmates may provide health service 
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researchers and prison officials with tools to evaluate and improve the delivery of HIV 
testing services in other state prison systems.   
The studies comprising this dissertation, which were based on analyses of existing 
administrative and laboratory records, did not provide any immediate benefits to the subjects. 
However, national studies have shown that 25% of released inmates are re-imprisoned within 
three years of release.48 Anecdotal reports suggest that these rates may be higher in NC.  
Consequently, subjects’ participation in this study may improve the HIV counseling and 
testing opportunities some participants encounter during future incarcerations.   
 
 
  
CHAPTER 3 
HIV TESTING IN STATE PRISONS:  BALANCING HUMAN RIGHTS AND PUBLIC 
HEALTH1 
 
With approximately a quarter of the one million HIV-infected individuals in the 
United States unaware of their infection,49 increased testing among high-risk populations has 
been promoted nationally.50 The importance of providing HIV testing to prison inmates—a 
population that generally suffers from a lack of routine community health care12, 13 and for 
whom the prevalence of HIV infection is several-fold higher than among the general 
population14—has been well documented for nearly 20 years.51-54 Although the potential 
individual and societal benefits of testing this high-risk population are substantial, 
considerable debate remains about the best practices for screening prison inmates for HIV 
infection. State legislators, public health officials, and prison administrators, among others, 
must consider whether HIV testing should be mandated for all inmates, and if not, the degree 
to which consent-based voluntary testing should be available, encouraged, and targeted. The 
HIV screening policies that states choose have implications for the protection of inmate 
rights and for the public health. In this review, I briefly describe current prison-based testing 
                                                 
1
 With minor revisions, first published as Rosen DL, Schoenbach VJ, Kaplan AH. HIV 
testing in state prisons: balancing human rights and public health.  Infectious Diseases in 
Corrections Report. April 2006; 9(4): 1-5. 
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practices, summarize issues raised in the existing debate and outline possible research and 
evaluation efforts to help guide future HIV testing practices in prison. 
 
Why Test?   
The potential benefits of HIV testing for both the inmates being tested and society at 
large are compelling. In contrast to non-incarcerated settings where HIV testing is typically 
prompted by illness and provided late in the course of infection,55, 56 screening asymptomatic 
inmates may allow for earlier diagnosis and consequently, more timely initiation of care, 
fewer opportunistic infections, and extended survival.57 Further, the confines of prison can 
help facilitate the receipt of HIV test results compared to community settings where failure to 
return for test results is common.17-19  In addition, testing coupled with counseling provides 
opportunities to engage inmates in discussions about risk reduction.   
For those inmates testing positive for HIV infection, access to healthcare has been 
affirmed by the Supreme Court58 and highly active antiretroviral therapy (HAART) is widely 
available in correctional settings.59 The effectiveness of HIV care in prisons has brought 
about a 75% reduction in AIDS-related mortality,20 a decline mirroring that of non-
incarcerated populations.60 Further, the structured environment and the provision of basic 
necessities in prison (e.g. food and shelter) may provide therapeutic support lacking in some 
community settings. As discussed in the March 2006 issue of Infectious Diseases in 
Corrections Report, ancillary services such as substance abuse and mental health treatment 
may also be more readily accessed in some prisons than in community settings, further 
supporting care. 
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In addition to entering HIV-infected inmates into treatment, HIV testing programs in 
prison have an important role in prevention. Identification of HIV-infected inmates can 
initiate contact tracing, thereby prompting others to be HIV tested and potentially hindering 
the spread of the virus within the community. With studies indicating that non-incarcerated 
individuals reduce their frequency of risk behaviors following HIV diagnoses24-26, inmates 
who are diagnosed in prison may also reduce HIV transmission behaviors both in prison and 
upon returning to the community.  Among those inmates who test positive and initiate care, 
successful maintenance of HAART minimizes infectiousness by reducing viral load in 
genital secretions, further reducing the risk of transmission.61, 62        
 
Negative Consequences of HIV Diagnosis in Prison 
Despite the benefits of HIV testing, there are also disincentives for inmates to be 
tested.  Inmates may be reluctant to be screened for HIV infection because of the fear that, if 
positive, information about their HIV status will disseminate throughout the prison to 
correctional staff and other inmates. The serostatus of HIV-infected inmates may be 
intentionally disclosed or, in the concentrated environment of prisons, unwittingly revealed 
by a number of activities associated with HIV care such as standing in a medication line, 
attending HIV specialty clinics, and receiving extra meals or nutritional supplements.63 The 
consequences of disclosure among inmates have not been well documented, but given that 
social hierarchies in prison may be reinforced by coerced and consensual sexual activity, 
disclosure of HIV status can be stigmatizing, diminishing social support and potentially 
provoking violence or the threat of violence.63   Institutional consequences of testing positive 
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may include loss of access to activity programs, visitation, and jobs, as well as housing 
restrictions.64  
In the past, some state prison systems have segregated HIV-infected prisoners from 
the general prison population as a means to prevent intra-prison transmission. Policies of 
segregation have been criticized for perpetuating stigma, forfeiting confidentiality, and 
restricting the opportunities (e.g. for education and work-release) of HIV-infected inmates.63, 
64
 Most agree that these policies have had little effect on diminishing already low rates of 
intra-prison transmission,65 and segregation has now fallen out of use in all but a few state 
prison systems.  
Some prison systems, however, cluster HIV-infected inmates in particular prisons to 
facilitate the provision of medical care and ancillary services. Policies of clustering differ 
from those of segregation in that they typically allow for HIV-infected inmates to live among 
the general prison population, which may reduce the consequences of breeches in 
confidentiality regarding HIV status.65 Criticism of clustering has been less vocal than that of 
segregation, and several state systems that cluster HIV-infected inmates have been noted for 
excellence in the provision of HIV care.59 However, like segregation, clustering can in effect 
breach inmates’ confidentiality and result in institutional restrictions, such as those listed 
above.   
 
Current Prison-Based HIV Testing Policies 
HIV testing policies in many prison systems (N=29) have been established by their 
respective state legislatures.66 In other states, testing policies have been developed by state 
health departments or prison administrators. In both cases, financial considerations—costs of 
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implementing a particular testing policy and providing treatment and care for identified 
cases—can play an important role in determining how HIV screening is conducted.59, 67  
Regardless of their policies’ origins, state prison systems can be broadly 
dichotomized into those that mandate HIV testing for all inmates and those that provide 
voluntary (i.e. consent-based) testing. A Bureau of Justice Statistics (BJS) publication 
reported that for the year 2000, 19 state prison systems employed mandatory testing at 
intake; four of these states also mandated testing upon release.33 The other 31 prison systems 
implemented voluntary HIV testing, with most of these systems providing opportunities for 
testing upon entry. At the time of the survey, four state systems with voluntary testing—
Texas, Florida, New York, and California—contained about half of the nation’s known HIV-
infected prison population.33   
Since the 2000 survey, the Texas68, 69 and Florida70, 71 prison systems have changed 
testing policies and now mandate HIV testing for all inmates preceding their release; 
California is considering such a policy. Other state systems to change testing policies since 
2000 include Michigan, which switched from voluntary to mandatory testing,72 and Nevada, 
which switched from mandatory to voluntary testing (see Figure 3.1). 70   
Voluntary testing can be offered in many different ways. In most systems inmates 
must request to be tested (“opt-in” testing) whereas in a few states, inmates are routinely 
provided testing unless they actively refuse (“opt-out” testing). Also, testing may target 
particular populations:  11 of the 31 systems with voluntary testing in 2000 specifically 
targeted “high risk” inmates33 (e.g. injection drug users, commercial sex workers) for HIV 
testing. As such, prison systems with policies of voluntary HIV testing encourage testing to 
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different degrees. Not unexpectedly, the rates of HIV testing in prisons with voluntary testing 
vary widely (39-71%).31, 42  
Some systems have different testing strategies depending on inmate status.  For 
example, Rhode Island, which has a single correctional facility that serves as both the state’s 
prison and jail, provides routine opt-out testing to arrestees; if convicted, inmates who 
refused testing at arrest undergo mandatory testing.73 Texas routinely tests inmates as they 
enter the prison system and mandates testing of all inmates upon release. 
 
Regardless of mandatory or voluntary policies, most prisons test inmates under the following 
circumstances: at an inmate’s request, if clinically indicated, upon involvement in an 
incident, such as a fight with blood exposure, and by court order,33 particularly for crimes of 
a sexual nature and sometimes for those that involve injection drug use. Testing under these 
circumstances, however, likely represents only a small proportion of all tests performed.   
 
Mandatory HIV Testing 
Of all the testing strategies, mandatory testing offers the greatest opportunity to 
diagnose HIV-infected inmates. The American Medical Association (AMA) endorsed 
mandatory HIV testing of prison inmates in 1987.74 More recently, Braithwaite and Arriola 
endorsed mandatory testing for inmates provided such testing is conducted in a non-
prejudicial manner and adequate treatment and follow-up resources are available.15 However, 
guidelines from the American Public Health Association (APHA) suggest that mandatory 
testing of inmates is inappropriate, and the World Health Organization (WHO) deems 
mandatory HIV testing in prison unethical and ineffective.35, 36   
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Arguing against mandatory testing, critics cite the inability to preserve confidentiality 
in prison63 and the discrimination and stigmatization that HIV-infected prisoners have 
historically endured, particularly as a result of segregation.26 Further, some feel that 
mandatory testing diminishes inmates’ opportunities to engage in thoughtful counseling 
about risk behaviors since testing will be conducted regardless of whether an inmate deems it 
necessary.75  
A study by Varghese and Peterman projected the number of HIV cases averted by 
providing counseling and testing (CT) in prison.76 The results indicated that in low-
prevalence settings (≤1%), the majority of averted cases (80%) resulted from seronegative 
inmates reducing their likelihood of acquiring HIV following CT; only 20% of cases were 
averted because newly diagnosed inmates reduced their potential risk of transmission 
following CT. Although this study was based on a number of assumptions, it implied that in 
prisons with a low prevalence of HIV, prisons requiring mandatory testing without (or with 
insufficient) counseling might be less effective at averting future cases of HIV than prisons 
that provide widespread counseling. It is noteworthy that in 2003, 13 of the 20 prison 
systems with mandatory testing had prevalence estimates of 1% or less.70, 77   
 
Voluntary ‘Opt-In’ HIV Testing  
Voluntary testing wherein the individual must actively consent (i.e. opt in) to HIV 
testing may preserve inmates’ autonomy, but existing literature, though dated, suggests that a 
substantial proportion of infected inmates remain undetected in systems with voluntary 
testing. Rates of HIV infection observed in seroprevalence studies exceeded rates of infection 
observed from voluntary testing in the Maryland, California, Illinois, New Jersey30 
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Wisconsin37 and Oregon38 state prison systems. Studies in the Maryland39 and Wisconsin37 
state prison systems, for example, reported that rates of HIV infection among those tested in 
blinded studies were twice that of volunteer testers.  In Wisconsin, 31% (8/26) of all HIV-
infected inmates declined to be tested, and in Maryland 66% (134/204) of all HIV-infected 
inmates declined testing.   
Unlike testing for other communicable infections, before testing for HIV infection, 
healthcare providers are required to counsel patients about risk behaviors and obtain written 
informed consent. Although these procedures were initiated to lessen potential, negative 
psychosocial repercussions of testing HIV-positive, some argue that they create undue 
obstacles for testing including additional time spent conducting the counseling and 
paperwork. Further, because the written consent process is unique to HIV, it may in fact 
further perpetuate stigma associated with being tested.78   
Additionally, identification of patients at risk for HIV infection who should be 
offered testing can be challenging. Patients are often reluctant to disclose behaviors related to 
transmission, and providers can be poor at eliciting information about these behaviors. 
Although approximately one-third of state prison systems with voluntary testing specifically 
target “high risk” inmates, the definition of “high risk” has not been well defined and likely 
varies across, and perhaps within, state prison systems. Several studies have identified factors 
associated with HIV infection among inmates, but the extent that these factors have been 
used to screen inmates--and their ability to identify new infections--has not, to our 
knowledge, been documented. Without validation, targeted testing may divert prevention and 
testing resources away from inmates at risk for infection.   
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Routine or Voluntary ‘Opt-Out’ Testing 
Recommendations for routine testing, both in community and correctional 
populations, have been gaining support over the last several years.78,59, 79 In community 
settings, the proportion of those tested as a routine part of medical care is on the rise.80 The 
CDC’s revised HIV testing guidelines, released in 2001, and its 2003 initiative, “Advancing 
HIV Prevention,” both recommend that routine testing be offered in settings with prevalence 
estimates of ≥ 1%, including correctional settings that fit this prevalence criterion.50, 81 A 
technical addendum to the 2003 initiative recommends routine testing in prisons without 
reference to the 1% prevalence cut-off.82  
Unlike voluntary opt-in testing, routine opt-out testing (i.e. conducting HIV screening 
unless the individual refuses to be tested) does not depend on patients’ self-disclosure of 
risky behaviors. It may help to normalize the testing process and decrease test-associated 
stigma, increasing acceptance of offered testing and potentially increasing new diagnoses. To 
further promote acceptability, some suggest that routine testing should be offered with 
minimal pre-test counseling; extensive counseling and services would be available for those 
testing positive.78   
The provision of routine HIV testing in the Rhode Island Department of Corrections 
has had a substantial impact on detecting infected individuals in that state. From 1989-1999, 
diagnoses among prison inmates constituted 33% of all new HIV diagnoses in Rhode 
Island.73 While this proportion includes convicted inmates who undergo mandatory testing, 
90% of inmates accepted routine testing upon entry.59   
Some inmate advocates suggest that opt-out testing conducted in prison, an inherently 
punitive environment, is coercive by nature and akin to mandatory testing.83 Corrections-
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based providers in Rhode Island counter that testing is not coercive, but rather is well-
accepted among inmates because it is coupled with comprehensive, prison-based treatment 
programs.79 In support of this argument, a study of released Rhode Island inmates found that 
77% of respondents endorsed HIV testing.84 Despite most respondents’ endorsement of 
testing, the high rates of acceptance raise questions about inmates’ autonomy; in two 
community-based studies of routine HIV testing, acceptance rates were 37%85 and 40%,86 
well below the 90% acceptance rates among Rhode Island inmates. In the Texas correctional 
system, which incarcerates more inmates than any other system in the United States,77 refusal 
of routine testing at intake has been reported to be less than 1%.68 
 
Future Research and Evaluation of HIV Testing Policies 
A variety of HIV testing policies are practiced in state prisons across the U.S. Each of 
these policies appears to have different implications for the protection of inmate rights (i.e. 
autonomy, confidentiality, and access to care) and for prevention of disease transmission in 
community settings. However, our understanding of these different policies is incomplete, 
based on anecdotal information and extrapolated from non-prison populations. The 
application of similar polices may vary greatly by state prison system and by prison. To truly 
evaluate these programs in regards to their impact on inmate rights and public health, I 
propose that the following areas be assessed:  
• Congruity between testing policies and their applications 
• Costs of testing, counseling, and prevention programs 
• Inmate, provider, and system characteristics associated with uptake of HIV testing in 
systems with voluntary testing 
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• Efficacy of counseling on the acceptance of HIV testing and the reduction of inmate risk 
behaviors  
• The roles of confidentiality and stigma in acceptance of testing 
• Psychosocial and physical (e.g. disease-related morbidity, target of assault) consequences 
of testing positive in prison 
• Utility of targeted testing 
• Availability of and access to services following release 
 
To our knowledge, only the last of these areas has received any attention. These 
evaluations could be couched as part of larger assessments of medical care in prison. 
Although there is certainly a disincentive for prisons to document their own lapses in care, a 
necessary first step to improving medical care and promoting public health through the 
prison system is to take a sober look at the services provided. Prison health care experts 
should work with governmental agencies to develop and implement these evaluations.   
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Figure 3.1. Prison systems with mandatory HIV testing and known HIV/AIDS 
cases as a percent of total custody population, 2003
Map created using data collected by the Bureau of Justice Statistics.  Please see references 31 and 34.
‘Mandatory HIV testing’ refers to systems that tested all inmates upon entry, during custody or upon 
release. 
  
CHAPTER 4 
RESEARCH DESIGN AND METHODS 
The specific aims of this dissertation are listed below followed by the rationale and 
hypotheses for each aim.   
Specific Aim 1. Determine system-wide and facility-specific HIV testing rates among inmates 
without a pre-existing HIV diagnosis, in a state prison system with voluntary HIV testing 
Specific Aim 2.  Identify inmate characteristics associated with receipt of an HIV test among 
inmates without a pre-existing HIV diagnosis  
Specific Aim 3. Identify inmate characteristics associated with HIV serostatus  
Specific Aim 4. Estimate the number of HIV-infected prisoners who remain untested in the 
North Carolina prison system 
 
Specific Aim 1. Determine system-wide and facility-specific HIV testing rates among inmates 
without a pre-existing HIV diagnosis, in a state prison system with voluntary HIV testing 
Rationale.  With an estimated 13-19% of HIV-infected US adults incarcerated annually, state 
prisons represent a unique opportunity to test individuals at high risk of infection but who 
have little access to regular health care, including HIV screening.  Rates of HIV testing in the 
NC DOC prison system, as in most systems with voluntary testing, are unknown.  
Examination of testing rates is necessary to characterize use of testing services and inform 
testing policies. Calculation of annual testing rates can be used to determine if testing 
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increased with expansion of the prison population and advances in therapeutics.  
Comparisons of testing rates from the NC DOC with national estimates and with rates from 
other state prison systems would characterize NC DOC services in the context of “industry” 
standards. Current literature does not acknowledge that testing rates may vary by facility 
within state prison systems.  A finding of substantial variation may prompt researchers to 
take a more nuanced view of system-wide testing rates and prompt prison administrators to 
ensure equal access to testing services.  Finally, studies of testing rates have largely been 
limited to new prison entrants; the additional determination of testing rates among inmates 
post-entry would more completely describe HIV testing in prison.   
Hypotheses 
Rate of HIV testing varies from one prison entrance facility to another. 
 
Specific Aim 2.  Identify inmate characteristics associated with receipt of an HIV test among 
inmates without a pre-existing HIV diagnosis  
Rationale.  Inmate characteristics associated with receipt of testing can be used to identify 
groups of inmates under-tested for infection.  Decreased testing among particular groups may 
be indicative of systematic barriers suggesting specific interventions.  For example, if 
depression was associated with decreased testing rates at admission, testing could be offered 
later in one’s sentence following the establishment of anti-depressant therapy.  More 
ominously, low rates of testing among inmates reporting high risk behaviors (e.g. injection 
drug use) could question the effectiveness of pre-test counseling.   
Previous studies examining the association between inmate characteristics and receipt 
of HIV testing have been conducted under the unsupported assumption that testing practices 
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do not vary among prisons within the same prison systems.  Failure to account for testing 
differences among facilities in the same prison system could result in biased effect estimates 
and overly-narrow confidence intervals.  We plan to improve upon previous studies by 
controlling for facility in our statistical models.    
Hypotheses. HIV testing is associated with entrance facility and is positively associated with 
greater number of prior incarcerations and history of behavioral risk factors; testing is 
inversely associated with history of mental health condition and African American race. 
 
Specific Aim 3.  Identify inmate characteristics associated with HIV serostatus 
Rationale. In addition to assessment of HIV testing, examination of HIV status among those 
tested may prove useful:  inmate characteristics associated with both low probability of 
testing and high probability of infection would support the need for expansion of targeted 
testing.  Further, the extent of HIV counseling may in large part be dependent on inmates’ 
willingness to report their engagement in high risk behaviors.  Given incomplete privacy in 
the prison, inmates may be reluctant to disclose high risk behaviors.  Examination of inmate 
characteristics associated with HIV infection, beyond self-reported risk behaviors, may be 
useful for the development of risk scores to improve HIV screening practices, and could be 
used to estimate the burden of HIV infection among untested inmates. 
Hypotheses. HIV infection is positively associated with African American race, female 
gender, older age, history of behavioral risk factors, history of mental health condition, and 
greater number of prior incarcerations. 
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Specific Aim 4.  Estimate the number of HIV-infected prisoners who remain untested in the 
North Carolina prison system 
Rationale.  In prison systems with voluntary HIV testing, it is likely that HIV cases remain 
undetected.  Quantifying the number of undetected cases could be helpful in determining the 
need for greater testing and treatment services.  Blinded seroprevalence testing is the 
standard for determining the extent of undetected HIV cases, but this method can be 
logistically difficult and expensive.  I introduce a simple alternative to blinded anonymous 
seroprevalence testing to estimate the extent of undetected HIV infection based on both 
community prevalence estimates in NC and on prevalences estimated from the NC DOC 
prison population tested for HIV.  It will be possible to compare these results with those from 
a blinded seroprevalence study, which is planned in the NC DOC next year.    
Hypothesis. At any given time, at least one-third of HIV cases in the prison system have not 
been detected.    
 
Study overview and analytic approach 
 The use of voluntary HIV testing was examined among the 54,016 inmates 
imprisoned in the North Carolina state prison system between January 2004 and May 30, 
2006.  All analyses were based on existing electronic HIV test records and imprisonment 
records, which included the following: socio-demographic information, imprisonment 
history, mental health diagnoses, conviction history, illicit substance use history, and intake 
prison.  These data were used to examine differences in HIV testing across the 8 intake 
prisons in the North Carolina prison system and to describe the use of HIV testing both 
during and after the intake process.  Associations between HIV testing (yes or no) and inmate 
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characteristics were examined. Among inmates voluntarily tested for HIV, associations 
between prisoner characteristics and HIV serostatus were examined. Age-sex-race specific 
HIV prevalence estimates among tested inmates.  These prevalence estimates and estimates 
obtained from state health department data were each used separately to estimate the number 
of undetected HIV cases existing among untested prisoners.   
 
Study setting 
The North Carolina Department of Correction (NC DOC) Division of Prisons 
maintains 76 prisons and at mid-year 2003 incarcerated 33,583 individuals.  During 2002-
2003, there were approximately 23,000 inmate admissions and a similar number of releases.  
In 2003, the distributions of race and age among new inmates were similar to those of 
existing inmates: 60% black, 30% white, and 10% other; 75% of inmates were between the 
ages of 22 and 45 years. Women comprised 12% of incoming inmates but only 7% of the 
total inmate population.87  While state data are not available, national data suggest that 25% 
of released prison inmates are re-imprisoned for a new crime within 3 years.48  In 2004, the 
last year with available data for the NC DOC, 1.8% of all inmates in custody were reported 
to be HIV infected.8  Since this estimate is based on voluntary testing, it very likely 
underestimates the true prevalence.     
 
Study cohort 
Adult prisoners, aged 18 years of age or older, admitted to the NC state prison system 
between January 1, 2004 and May 30, 2006 were eligible for inclusion in the analysis.  
Seventeen prisoners were excluded because they were admitted to a prison without a 
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processing center.  For Aims 1 and 2, the 631 prisoners who were tested for HIV despite a 
pre-existing HIV diagnosis (as documented by the N.C. State Health Department) were 
excluded to focus the analyses on inmates with unknown serostatus.  These 631 prisoners 
were included in the analysis of specific Aim 3.   
 
Intake, Infectious disease testing, and other assessments 
Before assignment to one of the 76 prisons in the NC DOC prison system, all 
incoming inmates are first admitted to one of eight intake prisons with a 
processing/diagnostic center.  Two centers are designated for adult women, four for adult 
males, and two for younger males (aged less than 22 years).  These eight centers assess 
inmates’ vocational skill, educational achievement, illicit substance use, and mental and 
physical health.   
A medical evaluation is completed for all inmates and includes routine testing for 
syphilis and tuberculosis (TB), and testing for hepatitis C (HCV) based upon clinical 
evaluation.  Inmates are screened for conventional HIV risk behaviors, and voluntary (i.e. 
consent-based) HIV testing is available.  It is NC DOC policy to encourage inmates with 
known risk behaviors to be tested.  Inmates self-reporting a previous HIV diagnosis may 
receive confirmatory testing before initiation of antiretroviral therapy.  HIV testing is also 
available anytime during incarceration following an incident with blood exposure, such as a 
fight; following the recommendation of a clinician; or upon inmate self-request.   
Assessments of inmates’ social (e.g. educational achievement, employment and 
marital status) and criminal histories are conducted by a NC DOC case analyst, and are 
informed by data collected prior to sentencing.  Psychological assessment is conducted in 
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several stages, beginning with an interviewer-administered 10-item screening instrument; 
prisoners responding affirmatively to questions on the screener or displaying unusual 
behavior are referred to a psychologist for further evaluation and possible diagnosis based on 
criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. 
 
Electronic records and data linking 
The NC DOC provided electronic records of data collected routinely for all inmates 
entering the state prison system between January 1, 2004 and May 31, 2006.  Records 
included socio-demographic information, conviction offense and sentence, dates of 
imprisonment, mental health diagnoses, and results from education, substance abuse and 
HIV-risk screenings.  Dates and results of all tests for syphilis, hepatitis C, and HIV 
conducted during the study period were provided in a separate database by Quest 
Diagnostics, a private company contracted by the NC DOC to process diagnostic lab work.   
Electronic prison data provided by the NC DOC and lab data provided by Quest were 
linked using a unique prison identification number (PIN) assigned to all inmates upon first 
admission.  The PIN was present in all prison records and missing in less than 3% of lab 
records.  Lab records with missing PINs were excluded from our analyses.  Prisoner records 
which linked to a lab record were coded to indicate the prisoner had been tested; prisoner 
records without a linked lab record were coded as not-tested.   
Through a collaborative arrangement, the North Carolina Department of Health and 
Human Services provided data indicating whether inmates testing positive for HIV in prison 
had been previously diagnosed within the state and the original diagnosis date.   
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Before analysis, each inmate record was assigned a unique study identification 
number, and all other identifying information (names, date of birth, and PIN) was removed 
from the data.  Only records of inmates 18 years of age or older at the time of prison 
admission were retained for analysis.   
Although interview data can provide a more nuanced understanding of factors 
affecting HIV testing and serostatus (see Aim 3) than inmate characteristics, strengths of this 
analysis include substantial sample sizes and the focus on characteristics that are largely free 
from the biases inherent in respondent self-report.   
 This project was approved by the Biomedical IRB within the University of North 
Carolina—Chapel Hill and the IRB of the North Carolina Department of Corrections.  
 
Coding of infectious disease testing and mental health conditions  
Inmates were classified as HIV-positive if both an enzyme-linked immunosorbent 
assay (ELISA) and Western blot were reactive; hepatitis C-positive with a positive antibody 
test; and syphilis-positive if Rapid Plasma Reagin (RPR) titre was 1:8 or greater.  All 
prisoners were assessed for TB using a Montoux screening test at admission. Since the 
Montoux results were not electronically available, electronic medication prescription data 
were used:  prisoners prescribed anti-TB medications within 30 days of admission were 
coded as having TB disease. 
Electronic records were used to identify prisoners who had been diagnosed with a 
mental health disorder within 30 days of admission.  The following diagnoses, based on 
DSM-IV criteria, were included for statistical analysis: (Axis I) psychosis, bipolar disorder, 
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major depression, generalized anxiety disorder, dementia, and (Axis II) developmental 
disorders and personality disorders. 
 
Data protection 
Electronic data were stored on a secure password-protected server; database files had 
additional password protection.  Paper records were stored in a locked file cabinet within a 
locked office located in the School of Medicine on the campus of UNC- Chapel Hill.  Similar 
measures to protect confidentiality have been successfully implemented by our research team 
in the past.  All personal identifiers were removed from the data and replaced with study ID 
numbers.  Data connecting patient identifiers and study ID were stored in a separate, 
password protected file.  All results were reported in aggregate to protect confidentiality.      
 
This dissertation is the product of a collaboration between the North Carolina Department of 
Correction and the UNC Division of Infectious Diseases. 
This project has been endorsed by the Medical Director of the NC Division of 
Prisons, Dr. Paula Smith, and proceeded as a collaboration between the Department of 
Correction and a team of UNC investigators.  Partnerships of this type are mutually 
beneficial – they are an important mechanism to lend research expertise to resource-poor 
settings (such as prisons) that are of great public health importance.  Conversely, input from 
prison officials, such as Dr. Smith, were crucial in directing research priorities and in 
ensuring that this and future projects are logistically compatible with the prison system 
environment and resources.  
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Consideration of ethical issues and status of IRB applications 
Before IRB submission, Dr. Schoenbach, Dr. Wohl, and I met with several members 
of the UNC Biomedical IRB to identify and discuss any aspects of the study that could 
potentially violate inmate rights.  This proposal reflects suggestions that arose from that 
meeting.  This study has been approved by the UNC Biomedical IRB, the North Carolina 
Department of Correction IRB.   
 
Statistical Analyses Aims 1 and 2:  HIV Testing is the Dependent Variable 
System-wide and center-specific proportions of inmates documented to be tested for 
HIV during their admission were tabulated.  For the 12% of prisoners with multiple 
imprisonments during the study period, only their most recent admission was included in 
these tabulations.  For all prisoners, admission was uniformly defined as spanning the first 21 
days of imprisonment (the admission process can last up to 21 days).  All HIV tests 
performed on or after imprisonment day 22 were defined as post-admission tests.  The post-
admission incidence rate of HIV testing, expressed as tests per 10 person-years, was 
estimated by dividing the total number of post-admission tests by the contributed number of 
post-admission person-days among those inmates not tested during admission.   
Testing proportions and rates were estimated separately for men and women.  For 
each gender, the overall proportions of inmates tested were estimated by each of the 
following characteristics assessed at entry: socio-demographic, intelligence score, 
imprisonment history, mental health, illicit substance use, syphilis and HCV infection, TB 
disease, and conventional HIV risk behaviors:  1) blood transfusion between 1978-1985, 2) 
sex with multiple partners, 3) sex as or with a sex worker, 4) shared needles, and 5) men who 
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have sex with men (men only).  Behaviors assessed exclusively among females included 6) 
sex with male injection drug users and 7) sex with men who have sex with other men.  For 
each of these prisoner-characteristic variables a test of the null hypothesis “no association 
with HIV testing” was performed using a chi-square test procedure of size α = 0.05. 
Associations between testing status and inmate characteristics were further 
investigated by fitting gender-specific log linear models for testing status (yes or no) 
conditional on independent variables such as (1) covariates that had statistically significant 
chi-square tests for associations with testing status, (2) binary covariates identifying the 
prisoner’s intake prison, and (3) a dichotomous (‘yes’ or ‘no’) summary variable for risky 
behavior with value ‘yes’ if and only if the prisoner had any of the conventional HIV risk 
behaviors.   The conventional risk behaviors included sex with multiple partners, sexual 
activity as or with a sex worker, sharing of needles, receipt of a blood transfusion during 
1978-1985, or for men, having sex with other men (MSM); for women only, risk behaviors 
also included sex with MSMs and sex with injection drug users.   
Collection of data describing conventional HIV risk behaviors was limited to only 
one of the two female facilities.  As a result, for females these data are included in the 
bivariate analyses only.  Conventional behavioral data were also missing for about 18% of 
men; missingness ranged between 35-43% in three facilities, but was less than 2% in the 
other three facilities.  To assess the effect of the missing data on the estimates, I conducted a 
complete case analysis, an analysis restricted to inmates entering the three intake prisons with 
< 2% missing behavioral HIV data, and an analysis based on multiple imputation.  
Imputation was carried out using the Amelia II algorithms (used in version 2.5.0 of R) 
because of its facility with categorical variables.88, 89  All other analyses were conducted 
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using SAS System Software (version 9.1, Cary, North Carolina).  The imputation model 
included all variables reported in the final model as well as six variables based on self-report 
indicating whether the prisoner ever 1) was told he or she had AIDS, 2) had a venereal 
disease, 3) had unexplained tiredness, weight loss, night sweats, diarrhea, 4) drank 
excessively, 5) used hard drugs, or 6) had TB. 
 
Statistical Analyses Aim 3:  HIV Serostatus is the Dependent Variable 
The proportion of HIV-infected prisoners was calculated for each level of the 
following: socio-demographic characteristics, conventional HIV risk behaviors, drug use, 
conviction history, mental health, TB disease, syphilis infection, and HCV infection.  For 
each prisoner characteristic variable a test of the null hypothesis “no association with HIV 
serostatus” was performed using a chi-square test procedure of size α = 0.05. 
Associations between HIV-serostatus and selected inmate characteristics were 
investigated further using gender-specific logistic regression models for HIV-serostatus 
conditional on selected covariates representing conventional IHV risk behaviors and 
variables which had statistically significant associations (p<0.05). 
Conventional HIV risk behaviors were only recorded for women admitted to one of 
the two intake facilities which process females.  Among men, risk behaviors assessments 
were recorded in all but 8% of records.  The logistic regression analyses were based on those 
records with recorded risk behavior assessments.   
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Statistical Analysis Aim 4:  Estimating number of HIV cases among the untested prison 
population 
Most female prisoners were tested for HIV, but more than two-thirds of male 
prisoners remained untested.  To estimate the number (N) of HIV cases among untested male 
prisoners, we stratified the population of untested males by age (5 categories) and race 
(black, white, other), and multiplied the number (Ni) of untested prisoners within each of 
these strata by corresponding stratum-specific prevalence estimates (^Pi ) obtained  from the 
population of male prisoners tested for HIV.  Thus, the estimate of the number of HIV cases 
( ^N) took the form of a weighted sum of prevalence estimates: 
^N    =   
15
 
i=1
 Σ   
^Pi Ni 
Similarly, 95% confidence intervals were estimated as 
             
^N
  
-/+ 1.96( 15 
i=1
 Σ  Ni2 Vi)1/2 
in which Vi is the stratum specific variance of 
^Pi.  Our estimate assumes that the age 
distribution of untested prisoners was fixed, the variances for the prevalence estimates were 
independent, and that the HIV prevalence among the untested population is approximately 
the same as the prevalance among the tested population. 
 The same approach was repeated using age- and race- specific prevalence estimates   
( ^Pi  ) for the general population of men in North Carolina.  State prevalence estimates among 
men were calculated by dividing the age- and race-specific number of North Carolina men 
known to be living with HIV, as reported to the state health department,90 by the 
corresponding stratum-specific population denominators of men derived from census data.  
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For enhanced stability of these state estimates, we pooled HIV case and census data from 
2000-2005.  
 
  
CHAPTER 5 
AN EVALUATION OF HIV TESTING IN A LARGE SOUTHERN PRISON SYSTEM 
 
Abstract 
Objective: Determine the use of voluntary HIV testing among state prisoners  
Methods: Among NC prisoners, calculate system-wide and facility-specific proportions and 
rates of adult inmates tested for HIV and estimate associations between testing status and 
inmate characteristics  
Results: Of the 54,016 inmates who entered prison between January 2004 and May 2006, 
20,820 (38%) were tested for HIV, 18,574 (89%) at admission.  Across the eight intake 
prisons, testing was >80% in both female facilities, but <15% in four of six male facilities.  
Prisoners with a documented history of heroin use, crack/cocaine use, conventional HIV risk 
behavior (e.g. sharing needles, multiple sexual partners, or MSM), or tuberculosis disease 
were at least 10% more likely to be tested than inmates without these characteristics.  
Nevertheless, greater than 60% of men reporting conventional risk behaviors were not tested.  
Before covariate adjustment, black men were 30% less likely than white men to be tested; in 
the multivariable regression model, this effect was attenuated to 13%. 
Conclusions: Receipt of an HIV test ranged widely across intake prisons, and many male 
inmates with documented risk of infection were never tested.
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Background 
Rates of Human Immunodeficiency Virus (HIV) are disproportionately high among 
incarcerated individuals as compared to the general US population.14  Although there is some 
evidence that HIV is transmitted within prisons, the majority of infections occur in the 
community. 91, 92  Given inmates’ limited access to community healthcare,12 prisons provide 
an important opportunity to conduct HIV testing.    
Among the benefits of testing, infected inmates can matriculate into medical care and, 
if clinically warranted, initiate highly active antiretroviral therapy (HAART).  HAART is 
now widely available in prison systems across the US, and prisoners have experienced 
declines in HIV-related mortality similar to those in the community.20, 21   A positive HIV test 
may also initiate contact tracing to identify infection among inmates’ sexual or drug-using 
partners in the community and in prison.         
HIV testing strategies vary across US state prison systems.  According to the Bureau 
of Justice Statistics, 22 state prison systems have instituted mandatory HIV testing.  The 
other 27 prison systems provide consent-based testing (data from one state system, Alaska, 
were unavailable).29  Nearly all provide testing upon prisoners’ self-request.  Among systems 
with consent-based testing, at least two provide opt-out testing,93 and 7 target testing at “high 
risk” prisoners.  Yet little is known about the extent of HIV testing in prisons with consent-
based testing or the degree that testing in these systems includes prisoners with known risk 
factors for infection.  In addition, most existing US studies examining use of voluntary HIV 
testing were conducted before the era of HAART and few characterize differences between 
testers and non-testers.31, 32, 37, 39, 42, 94   
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In 2003, as part of its Advancing HIV Prevention initiative, the Centers for Disease 
Control and Prevention (CDC) recommended that “[c]orrectional systems should routinely 
offer HIV testing as a component of the standard medical intake evaluation for all inmates.”47  
With the CDC’s 2006 recommendations to improve access to HIV testing with 
implementation of routine opt-out testing across health care settings, including correctional 
health-care facilities,95 it is of renewed interest to examine the extent of HIV testing in 
prisons with consent-based testing.  Low rates of testing may indicate missed opportunities to 
provide needed medical care and social support, reduce infectiousness via treatment, and 
provide counseling to reduce secondary transmission.   
In this study, we examined the use of consent-based HIV testing in a large southern 
prison system, the North Carolina Department of Correction (NC DOC) Division of Prisons.  
Like other large prison systems, the NC DOC has several intake prisons into which inmates 
first enter before being transferred to the greater prison system.96  At these intake prisons, 
inmates receive a series of assessments including a medical evaluation and the opportunity to 
be tested for HIV.  Inmates self-reporting a previous HIV diagnosis may receive 
confirmatory testing before initiation of antiretroviral therapy.  HIV testing is also available 
anytime during incarceration by inmate self-request, clinician recommendation, or after a 
blood exposure incident.   
To assess the use of HIV testing, we determined the proportion of all inmates tested 
for HIV both during and after admission, examined differences in testing across intake 
prisons within the state system, and evaluated degree of association between receipt of an 
HIV test and prisoner characteristics in order to detect disparities in testing, particularly 
among inmates with documented risk for infection.   
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Methods 
Medical evaluation at intake prisons  
Before assignment to one of the 76 prisons in the NC DOC prison system, all 
incoming inmates are first admitted to one of eight intake prisons with a 
processing/diagnostic center.  Two centers are designated for adult women, four for adult 
males, and two for younger males (aged less than 22 years).  These eight centers assess 
inmates’ vocational skill, educational achievement, illicit substance use, and mental and 
physical health.  The medical evaluation is completed for all inmates and includes routine 
testing for syphilis and tuberculosis (TB), and testing for hepatitis C (HCV) upon clinical 
evaluation.  Inmates are screened for conventional HIV risk behaviors, and voluntary (i.e. 
consent-based) HIV testing is available; it is NC DOC policy to encourage inmates with 
known risk behaviors to be tested.   
Assessments of inmates’ social (e.g. educational achievement, employment and 
marital status) and criminal histories are conducted by a NC DOC case analyst, and are 
informed by data collected prior to sentencing.  Psychological assessment is conducted in 
several stages, beginning with a 10-item screening instrument; prisoners responding 
affirmatively to questions on the screener or displaying unusual behavior are referred to a 
psychologist for further evaluation and possible diagnosis based on criteria of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM)-IV. 
 
Electronic records and data linking 
The NC DOC provided us electronic records of data collected routinely for all 
inmates entering the state prison system between January 1, 2004 and May 31, 2006.  
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Records included demographic and social information, conviction offense and sentence, 
dates of imprisonment, mental health diagnoses, and results from education, substance abuse 
and HIV-risk screenings.  Dates and results of all tests for syphilis, hepatitis C, and HIV 
conducted during the study period were provided in a separate database by Quest 
Diagnostics, a private company contracted by the NC DOC to process diagnostic lab work.   
Electronic prison and lab data were linked using a unique prison identification 
number (PIN) assigned to all inmates upon first admission.  The PIN was present in all prison 
records and missing in less than 3% of lab records.  Lab records with missing PINs were 
excluded from our analyses.  Prisoner records which linked to a lab record were coded to 
indicate the prisoner had been tested; prisoner records without a linked lab record were coded 
as not-tested.   
Through a collaborative arrangement, the North Carolina Department of Health and 
Human Services provided data indicating whether inmates testing positive for HIV in prison 
had been previously diagnosed within the state and the original diagnosis date.  Prisoners 
with an existing diagnosis, as indicated by state data, were excluded from our study 
population to focus the analyses on prisoners with unknown serostatus.  
Before analysis, each inmate record was assigned a unique study identification 
number, and all other identifying information (names, date of births, and PIN) was removed 
from the data.  Only records of inmates 18 years of age or older at the time of prison 
admission were included for analysis.   
 This project was approved by the Biomedical IRB within the University of North 
Carolina—Chapel Hill and the IRB of the North Carolina Department of Corrections.  
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Coding of TB disease and mental health conditions  
All prisoners were assessed for TB using a Montoux screening test at admission. 
Since the Montoux results were not electronically available, electronic medication 
prescription data were used:  prisoners prescribed anti-TB medications within 30 days of 
admission were coded as having TB disease.  
Electronic records were used to identify prisoners who had been diagnosed with a 
mental health disorder within 30 days of admission.  The following diagnoses, based on 
DSM-IV criteria, were included for statistical analysis: (Axis I) psychosis, bipolar disorder, 
major depression, generalized anxiety disorder, dementia, and (Axis II) developmental 
disorders and personality disorders.  Prisoners diagnosed with both Axis I and II diagnosis 
were coded for Axis I only.   
 
Statistical analysis strategy 
We calculated the system-wide and prison-specific proportions of inmates tested for 
HIV during their admission.  For the 12% of prisoners with multiple imprisonments during 
the study period, only their most recent admission was included in the analyses.  For all 
prisoners, admission was uniformly defined as spanning the first 21 days of imprisonment 
(the admission process can last up to 21 days).  All HIV tests performed on or after 
imprisonment day 22 were defined as post-admission tests.  The post-admission incidence 
rate of HIV testing, expressed as tests per 10 person-years, was estimated by dividing the 
total number of post-admission tests by the contributed number of post-admission person-
days among those inmates not tested during admission.  HIV testing proportions, based on 
testing at any time during imprisonment, were calculated separately for men and women by 
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levels of the 22 variables derived from the following domains and characteristics assessed at 
entry: socio-demographic, intelligence score, imprisonment history, mental health, illicit 
substance use, TB disease, syphilis and HCV infection, and conventional HIV risk behaviors. 
Associations between testing status and inmate characteristics were further 
investigated by fitting gender-specific log linear models for the prisoners’ testing status (yes 
or no) was fitted in a manner which provided a test of size α = 0.05 of the null hypothesis 
“testing rate is invariant across the levels of that independent variable.”  In the second step, a 
gender specific log-linear regression model for testing status was fit conditional on the 
inmate characteristic of interest and also accounting for covariates such as (1) other 
characteristics that were statistically significant in the first step, (2) binary covariates 
identifying the prisoner’s intake prison, and (3) a dichotomous (‘yes’ or ‘no’) summary 
variable for risky behavior with value ‘yes’ if and only if the prisoner had any of the 
following conventional HIV risk behaviors: sex with multiple partners, sexual activity as or 
with a sex worker, sharing of needles, receipt of a blood transfusion during 1978-1985; men 
having sex with other men (MSM), which was only assessed among men and two other 
behaviors, sex with MSMs and sex with injection drug users, which were only assessed 
among women.  The fitted model was then used to perform a test of size α = 0.05 of the null 
hypothesis “covariate-adjusted testing rate is invariant across the levels of that independent 
variable.” 
Collection of data describing conventional HIV risk behaviors occurred in only one of 
the two female intake prisons.  As a result, the females with missing data were not included 
in the multivariable log-linear regression analysis.  Conventional risk behavioral data were 
also missing for about 18% of men.  In three of the six intake prisons for men, less than 2% 
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of data were missing. In the other prisons, between 35% and 43% of behavioral data were 
missing.  To assess the effect of the missing data on the magnitude and precision of our 
estimates, we conducted a complete case analysis, an analysis restricted to intake facilities 
with nominal missing data, and an analysis based on multiple imputation of missing data.  
Imputation was carried out using Amelia II algorithms (using version 2.5.0 version of R) 
because of its facility with categorical variables.88, 89  The multiple imputation model 
included the 22 variables evaluated in the complete case analyses; to enhance model 
saturation, an additional six variables which were of little analytic interest (e.g. Excessive 
drinking, Ever tired) were also included in the imputation model.  Five imputation datasets 
were generated.  The imputed data sets were analyzed using PROC MIANALYZE in SAS 
System Software (version 9.1, Cary, North Carolina).  All other analyses were also 
conducted in SAS. 
 
Results 
During the study period 54,664 inmates aged 18 years or older entered the North 
Carolina state prison system; 17 of these prisoners were excluded from our analysis because 
they were admitted to a prison without a processing center.  We also excluded the 631 
prisoners who were tested for HIV despite state health department records indicating a pre-
existing HIV diagnosis, in order to focus our analyses on the testing of prisoners with 
unknown HIV serostatus. 
Eighty-six percent of all inmates were male (Table 5.1). Across socio-demographic 
and imprisonment domains, a greater proportion of males than females were black, employed 
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before their incarceration, and recidivists; similar proportions of males and females were 
married.   
Women were nearly three times as likely as men to report heroin use (5.8% vs. 1.9%) 
and nearly two times as likely as men to report crack or cocaine use (63.0% vs. 32.7%).  
History of drug-related conviction was only slightly more common among women, but men 
were nearly five times as likely as women to have ever been convicted of a sex-related 
conviction.  A majority of males, but not females, had been imprisoned before. The median 
sentence length was 12.2 (25th, 75th percentiles: 3.2, 24.3) months for males and 3.2 (25th, 
75th percentiles: 2.0, 14.2) months for females.   
Intake facilities differed by median age and percent non-white.  In the two female 
facilities, the median ages were 33 and 35 years, and the percent non-white was 44.9% and 
47.2%. In the male facilities, the median ages in the two prisons for young adults were 18 
and 21 years, and ranged between 33 and 36 years for the other intake prisons.  The 
proportion non-white in the male intake prisons ranged from 52.3% to 72.9%. 
 
HIV testing 
Thirty-four percent (n=18,435) of all entrants received an HIV test during admission 
(i.e. before day 22 of imprisonment), but the proportion tested varied from 1 to 84% across 
processing centers: within each female processing center greater than 80% of entrants were 
tested for HIV; within four of the six male processing centers, fewer than 15% of entrants 
were tested (Figure 5.1).    
The 34,217 inmates not tested for HIV during admission were imprisoned for a total 
of 20,143 person-years during the study period.  Among these inmates, 2,228 (6.5%) were 
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tested for HIV at a rate of 1.1 tests per 10 person-years imprisoned. Post-admission tests 
constituted 10.7% (2,228/20,802) of all HIV tests.   
Among female prisoners, 85.7% were tested for HIV (Table 5.2) during admission or 
post-admission.  In the first step of the model based analyses for women, statistically 
significant associations with HIV testing were observed for 5 of the 22 prisoners 
characteristics: Race, Previous Time Served, and Sentence Length.  Compared to white 
women, non-white non-black (i.e. “other”) women were less likely to be tested for HIV 
(RR=0.86, 95% CI: 0.80, 0.93). Also, women were less likely to be tested if they had never 
been imprisoned in the NC DOC previously (RR=0.92, 95% CI: 0.90, 0.94).  Compared to 
women with sentences of less than three months, women with sentences of 3-6 months or 7-
18 months were more likely to be tested (3-6 months: RR=1.09, 95% CI: 1.06, 1.11; 7-18 
months: RR=1.07, 95% CI: 1.04, 1.10), but those with sentences of 19 months or greater 
were less likely to be tested (RR=0.89, 95% CI: 0.85, 0.93).  In the one intake facility that 
assessed risk behavior, women affirming a history of conventional HIV risk behaviors 
(defined in the methods section) were no more likely to be tested than women who denied 
these behaviors.   
In the second step of the model-based analyses for women (Table 5.4) estimation of 
testing rates for levels of each prisoner characteristic of interest accounted for the prisoner’s 
intake facility, and accounted for race, previous time served, sentence length, and the 
summary variable for risky behavior.  Comparisons of the covariate-adjusted testing rates 
indicated that the largest discrepancy in test was by race:  women categorized as “other” 
were 14% less likely to be tested for HIV than white women (RR=0.86, 95% CI: 0.80, 0.93).  
There was a modest effect for intake prison (RR=0.94, 95% CI: 0.92, 0.96). 
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Among male prisoners, 31.7% were tested for HIV during admission or post-
admission.  Testing rates were higher than average for men reporting risk behaviors such as a 
history of sharing needles (34.9%), prostitution (37.9%), or MSM (38.8%), but few men (i.e. 
less than 5%) disclosed participation in any of these behaviors (Table 5.3).  In the first step of 
the model-based analyses for the men, all 22 of the covariates except MSM, needle sharing, 
and syphilis were associated with test receipt.  Notably, males categorized as black and 
“other” were, respectively, nearly 30% and 40% less likely to be tested for HIV than whites. 
In the second step of the model-based analyses for men (Table 5.4), estimation of 
testing rates by levels of each patient characteristic accounted for the prisoner’s intake 
facility as well as individual characteristics except those 3 variables found to have no 
association with test receipt in step one.  Comparisons of the covariate-adjusted testing rates 
indicated that male prisoners with a history of heroin use, cocaine/crack use, HIV-specific 
behaviors, and a medication history indicative of TB disease were at least 10% more likely to 
be tested for HIV than those without these attributes (Table 5.4).  Black males were 13% less 
likely to be tested for HIV than white males (RR=0.87, 95% CI 0.85, 0.90).  After adjustment 
for covariates, intake prison effects were still substantial: Male intake prison 2 [M2] 
(RR=0.33, 95% CI: 0.31, 0.35), M3 (RR=0.39, 95% CI: 0.35, 0.44), M4 (RR=0.90, 95% CI: 
0.87, 0.92), M5 (RR=0.16, 95% CI: 0.13, 0.19), and M6 (RR=0.14, 95% CI: 0.12, 0.15). 
Results from the analysis restricted to intake facilities with nominal missing data 
(<2%) and the analysis based on multiple imputation were nearly identical to results of the 
complete case analysis (Appendix Table 5.5).  Notable exceptions included the multiple 
imputation analysis results for “other” race, no previous time served, and positive syphilis 
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results, all of which were attenuated in comparison to results from the complete case 
analysis.  
 
Discussion 
As national guidelines promote widespread access to HIV testing, it is important to 
assess the use of testing among high risk populations including prisoners.  In this study, we 
found that nearly forty percent of prisoners were tested for HIV, and the vast majority of tests 
were conducted as part of the admission process.  Although testing varied modestly by 
prisoner characteristics and reported risk behavior, it varied widely across admission 
facilities.  This is an important observation given that prior studies of HIV testing have been 
conducted in smaller prison systems with only a single intake facility or without regard to 
multiple intake facilities.31, 32, 37, 39, 42, 94  For future evaluations of HIV testing in other large 
prison systems, we suggest that testing rates be examined both across and within intake 
facility.   
There has been little previous research investigating organizational factors associated 
with HIV testing in correctional facilities, which might explain the variation in facility testing 
rates across intake facilities.  Results from one study examining the relationship between 
organizational structure and HIV testing in a national sample of correctional facilities found 
that organization size was a predictor of testing, but other constructs were not.97  In our data, 
there was no apparent relationship between organization size and testing practices.  Brief 
interviews with key informants indicated that facility differences were largely a reflection of 
different priorities assigned by the chief medical professional at each facility; in the two 
female facilities, high testing rates were explained by the use of opt-out testing as a standard 
 53 
component of reproductive healthcare.  Formal evaluations of the relationship between 
organizational structure and HIV testing could yield other useful insights.  
In nearly all state prison systems, including North Carolina’s, HIV testing is available 
throughout inmates’ incarceration following an incident with blood exposure, upon clinical 
recommendation, or upon the inmates’ request.  However, in our study population, the 
proportion of prisoners tested for HIV following admission was relatively small (6%).  
Providing periodic opportunities for prisoners to be tested for HIV could increase uptake of 
testing, and repeat testing of prisoners testing negative at admission could be useful in 
monitoring intra-prison transmission.91  In the NC DOC periodic testing of women would be 
less useful given their high rate of testing upon admission and short sentences.   
Of concern, nonwhites were less likely to be tested for HIV compared to whites:  
women whose race was categorized as other (i.e. neither white nor black) were 14% less 
likely to be tested than white women, and men categorized as other or black were 40% and 
30%, respectively,  less likely to be tested than white men.  
For men, much of the difference in testing across racial category may be explained by 
differences in the racial composition and testing rate of the intake prisons.  The intake prison 
with the greatest number of non-whites (M2) tested less than 10% of all inmates.  The extent 
that race affected testing rate, however, is unclear.  Nevertheless, after accounting for intake 
prison and prisoner characteristics associated with testing, black men and “other” women 
were still less likely to be tested for HIV than whites.  Other studies of among prisoners have 
also reported lower testing rates among non-whites.37, 39, 41  Given the higher prevalence of 
HIV among nonwhites as compared to whites,8 greater testing of nonwhites is an important 
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step in improving case finding.  More effort is needed to understand prisoners’ potential 
reluctance to be tested as well as the institutional barriers to testing.   
Among males, prisoner reporting any conventional HIV risk behavior, heroin use, or 
crack/cocaine use were 10% more likely to be tested for HIV than prisoners not disclosing 
these behaviors, and prisoners with TB disease were 20% more likely to be tested than 
prisoners without TB.  However, prisoners with active syphilis infection were no more likely 
to be tested for HIV than those without syphilis infection, and though only a small proportion 
(~10%) of prisoners was tested for hepatitis C, we found an inverse relationship between 
hepatitis C seropositivity and HIV testing.  With syphilis, hepatitis C, and HIV sharing routes 
of transmission, greater testing among syphilis- and hepatitis C-infected populations may 
yield a relatively high proportion of HIV-infected individuals.     
The CDC has recommended that HIV testing be available widely and offered 
routinely (i.e. via opt-out testing) in correctional health care facilities.47, 95  Routine HIV 
testing in prisons could potentially have a profound impact on case identification. In Rhode 
Island, which maintains a jail and prison in a single facility, HIV testing is routinely offered 
to all individuals pre-trial; those who refuse consent-based testing receive mandatory testing 
if convicted.  Ninety percent of Rhode Island prisoners accept routine testing.59  Under this 
system, the Rhode Island Department of Corrections detected about a third of all HIV-
infections in the state during the 1990s.73  In comparison, only about 7% of new HIV cases in 
North Carolina are detected in correctional facilities.98  Expanding HIV testing in the NC 
prison system may be an efficient way to improve case finding in the state.   
However, any expansion in testing must be done with caution: in the prison setting, 
which is designed to limit personal liberties, there is a fine line between encouragement and 
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coercion.  In a recent qualitative study of prisoners’ attitudes towards HIV testing in 
correction facilities, some inmates reported that HIV testing in their prison was mandatory 
despite residing in prisons with a policy of voluntary testing.99  With such misperceptions (or 
inconsistent application of policy), the 90% acceptance rate in Rhode Island causes some 
concern when compared to the 40% acceptance rate of opt-out testing reported in community 
settings.85, 100  Notwithstanding suggestions that Rhode Island prisoners are willing to be 
tested for HIV because the availability of comprehensive medical care has been well 
established,84 state prison systems should ensure that consent-based HIV testing is truly 
voluntary. 
In the NC DOC, prisoners disclosing their positive HIV status to medical staff are 
frequently provided confirmatory testing before antiretroviral medications are initiated. To 
focus our analyses on the testing of prisoners with unknown HIV serostatus, we excluded 
from our main analyses prisoners who were tested for HIV despite state (health department) 
records indicating a pre-existing HIV diagnosis.  We note, however, that these prisoners 
comprised 80% of all prisoners with an HIV-positive test result (Chapter 6).  Although half 
of these prisoners were first diagnosed in a correctional facility, failure to account for 
confirmatory testing would have greatly overstated the effectiveness of voluntary testing to 
detect new cases.  It is important for studies of HIV testing to distinguish between new and 
repeated HIV diagnoses.  
This study has a few limitations.  We were unable to link a small proportion of lab 
records (3%) to prison records.  It is not possible to determine if these unlinked lab records 
correspond to inmates in our study population or inmates who entered prison before the study 
period began.  Second, this study relies on routinely collected administrative data.  Validation 
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of administrative data would have been desirable, but was not possible because of the 
retrospective design of this study.  Third, about 23% of data specific to HIV risk behaviors 
were missing.  These missing data limited the scope of our covariate-adjusted analysis of 
testing among women. For the men, we assessed the effect of the missing data by comparing 
the results from a complete case analysis, a restricted population with nominal missing data, 
and an analysis using (multiply) imputed data; the effect estimates across analyses differed 
little.  Finally, data from the state department of health allowed us to exclude from the 
analyses prisoners testing positive for HIV who previously had been diagnosed in North 
Carolina; however, we were unable to identify and exclude prisoners who declined testing 
because of a previous diagnosis.   
Prisons have been well recognized as an important point of contact with populations 
who are at increased risk of disease and who often go without routine medical, dental, and 
mental health care. Programs to provide these services should be evaluated regularly and 
modified based on findings.  Evaluation of HIV testing programs in prison could lead to 
improvements in case ascertainment.  In this study we found that there were wide variations 
in testing across intake facilities, racial disparities in testing, and few tests provided after the 
admission process.  The NC DOC is reviewing these findings and working with medical staff 
to improve and unify testing services.  Additional studies are currently being initiated to 
assess prisoners’ and providers’ perspectives of the HIV testing process. Other state prison 
systems with consent-based testing could benefit from similar analyses as the role of prisons 
expands in HIV case detection.   
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Table 5.1. Characteristics of adult prisoners entering the North Carolina
state prison system, January 2004 - May 2006
Women Men
N=6,804 N=47,212
Age group (years)
≥ 45 12.4 % 14.0 %
35 - 44 33.8 25.9
25 - 34 36.3 34.2
18 - 24 17.6 25.9
Race
Black 42.2 55.5
Other 3.5 6.3
White 54.3 38.1
Education
College 13.5 7.3
HS degree or GED 46.2 47.0
Less than high school 40.3 45.6
Employed* 34.4 64.0
Married* 15.6 14.6
IQ test result
≤ 80 13.5 25.2
81 - 100 54.3 55.3
≥ 101 32.3 19.5
Previous time served (months)
None 60.5 44.0
> 0 - 6 15.0 13.9
7 - 12 10.3 10.1
≥ 13 14.2 32.0
Sentence length (months)†
≥ 19  16.6 30.9
7 - 18 22.2 25.9
3 - 6 29.9 22.8
< 3 31.3 20.4
Drug-related conviction ever 40.4 37.5
Sex-related conviction ever 1.3 6.2
Cocaine or crack use ever 63.0 32.7
Heroin use ever 5.8 1.9
MSM‡ -- 0.7
Multiple sexual partners‡ 26.4 21.2
Prostitution‡ 16.1 5.9
Share Needles‡ 9.0 3.0
Blood transfusion‡ 2.8 0.7
Sex with Needle Sharer§ 15.6 --
Sex with MSM§ 2.9 --
Mental health\
Axis I 6.5 2.3
Axis II 4.5 2.7
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Table 5.1. Characteristics of adult prisoners entering the North Carolina
state prison system,  January 2004 - May 2006 (cont.)
Women Men
N=6,804 N=47,212
Hepatitis C
Positive 7.6 % 3.2 %
Negative 2.1 1.1
No test 90.3 95.7
Syphilis
Positive 5.2 4.1
Negative 83.4 71.9
No test 11.4 23.9
Tuberculosis 
Positive 1.0 3.8
Negative 99.0 96.2
*data missing for ≤  20 observations per gender
†data missing for 471 (6.9% of) women and 2376 (5.0% of) men
‡data not collected from 3976 (58% of) women and 8333 (18% of) men
§data not collected from 3976 (58% of) women and all men
\Axis I: psychosis, bipolar disorder, major depression, generalized 
anxiety disorder, and dementia; Axis II: personality disorder, 
developmental disability 
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Table 5.2. Associations between HIV test receipt and characteristics of adult female
North Carolina state prisoners, admitted January 2004 - May 2006
    HIV-Tested
n % (n) RR 95% CI
Age group (years)
≥ 45 842 84.6 (712) 0.98 (0.94, 1.02)
35 - 44 2,299 85.2 (1958) 0.99 (0.96, 1.02)
25 - 34 2,468 86.3 (2130) 1.00 (0.97, 1.03)
18 - 24 1,195 86.3 (1031) 1
Race
Black 2,873 85.4 (2454) 0.99 (0.97, 1.01)
Other 236 74.6 (176) 0.86 (0.80, 0.93)
White 3,695 86.6 (3201) 1
Education
College 919 83.5 (767) 0.96 (0.93, 0.99)
HS grad or GED 3143 85.5 (2687) 0.99 (0.97, 1.01)
Less than high school 2,742 86.7 (2377) 1
Employment* 
Unemployed 4,459 86.7 (3865) 1.03 (1.01, 1.06)
Employed 2,343 83.8 (1964) 1
Marital Status
Not married/separated 5,743 86.1 (4946) 1.03 (1.00, 1.06)
Married 1,061 83.4 (885) 1
IQ test result
≤ 80 918 84.9 (779) 1.01 (0.98, 1.04)
81 - 100 3,691 86.8 (3204) 1.03 (1.01, 1.05)
≥ 101 2,195 84.2 (1848) 1
Previous time served (months)
None 4,114 82.5 (3392) 0.92 (0.90, 0.94)
> 0 - 6 1,019 90.6 (923) 1.01 (0.98, 1.04)
7 - 12 703 92.2 (648) 1.03 (1.00, 1.06)
≥ 13 968 89.7 (868) 1
Sentence length (months)†
≥ 19  1050 74.4 (781) 0.89 (0.85, 0.93)
7 - 18 1,409 89.3 (1258) 1.07 (1.04, 1.10)
3 - 6 1,892 90.9 (1720) 1.09 (1.06, 1.11)
< 3 1,982 83.7 (1658) 1
Drug-related conviction ever
Yes 2,748 88.0 (2417) 1.04 (1.03, 1.07)
No 4,056 84.2 (3414) 1
Sex-related conviction ever
Yes 91 75.8 (69) 0.88 (0.79, 0.99)
No 6,713 85.8 (5762) 1
Heroin use ever
Yes 396 89.9 (356) 1.05 (1.02, 1.09)
No 6,408 85.4 (5475) 1
Cocaine or crack use ever
Yes 4,283 87.8 (3761) 1.07 (1.05, 1.09)
No 2,521 82.1 (2070) 1
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Table 5.2. Associations between HIV test receipt and characteristics of adult female
North Carolina sate prisoners, admitted January 2004 - May 2006 (cont.)
    HIV-Tested
n % (n) RR 95% CI
Multiple sexual partners‡
Yes 748 84.9 (635) 1.00 (0.97, 1.04)
No 2,080 84.8 (1763) 1
Prostitution‡
Yes 455 85.3 (388) 1.01 (0.97, 1.05)
No 2,373 84.7 (2010) 1
Shared needles‡
Yes 254 87.8 (223) 1.04 (0.99, 1.09)
No 2,574 84.5 (2175) 1
Blood transfusion‡
Yes 79 83.5 (66) 0.98 (0.89, 1.09)
No 2,749 84.8 (2332) 1
Sex with Needle Sharer‡
Yes 442 87.1 (385) 1.03 (0.99, 1.07)
No 2,386 84.4 (2013) 1
Sex with MSM‡
Yes 82 87.8 (72) 1.04 (0.95, 1.13)
No 2,746 84.7 (2326) 1
Mental health§
Axis I 440 83.4 (367) 0.97 (0.93, 1.01)
Axis II 308 87.3 (269) 1.02 (0.97, 1.06)
Neither 6,056 85.8 (5195) 1
Hepatitis C
Positive 517 91.3 (472) 1.02 (0.96, 1.09)
Negative 140 89.3 (125) 1
No test 6,147 85.2 (5234)
Syphilis
Positive 353 96.3 (340) 1.00 (0.98, 1.02)
Negative 5,677 96.2 (5460) 1
No test 773 4.0 (31)
Tuberculosis 
Positive 66 81.8 (54) 0.95 (0.85, 1.07)
Negative 6,738 85.7 (5777) 1
*data missing for ≤ 20 observations 
†87.9% (414/471) of prisoners with missing data were tested for HIV
‡ 87.8% ( 3433/3976) of prisoners with missing data were tested for HIV
§Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, 
and dementia; Axis II: personality disorder, developmental disability 
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Table 5.3 Associations between HIV test receipt and characteristics of adult
male North Carolina state prisoners, admitted January 2004 - May 2006
     HIV Tested
n % (n) RR 95% CI
Age group (years)
≥ 45 6604 36.6 (2415) 1.94 (1.84 ,2.03)
35 - 44 12243 38.3 (4690) 2.03 (1.94, 2.12)
25 - 34 16136 34.4 (5557) 1.82 (1.75, 1.90)
18 - 24 12229 18.9 (2309) 1
Race
Black 26221 27.7 (7272) 0.71 (0.70, 0.73)
Other 2992 23.6 (707) 0.61 (0.57, 0.65)
White 17999 38.9 (6992) 1
Education
College 3464 35.7 (1237) 1.24 (1.18, 1.30)
HS grad or GED 22209 33.8 (7524) 1.18 (1.14 ,1.21)
Less than high school 21539 28.8 (6210) 1
Employment
Unemployed 17006 26.9 (4581) 0.78 (0.76, 0.81)
Employed 30187 34.4 (10385) 1
Marital Status
Not married/separated 40295 31.4 (12644) 0.93 (0.90, 0.97)
Married 6897 33.7 (2325) 1
IQ test result
≤ 80 11893 26.4 (3141) 0.69 (0.66, 0.71)
81 - 100 26098 31.7 (8280) 0.82 (0.80, 0.85)
≥ 101 9221 38.5 (3550) 1
Previous time served (months)
None 20793 27.0 (5604) 0.74 (0.72 ,0.77)
> 0 - 6 6540 34.7 (2269) 0.96 (0.92 ,1.00)
7 - 12 4777 34.2 (1634) 0.95 (0.90 ,0.99)
≥ 13 15102 36.2 (5464) 1
Sentence length (months)*
≥ 19  13860 30.0 (4161) 0.79 (0.76 ,0.82)
7 - 18 11610 31.1 (3615) 0.82 (0.79, 0.85)
3 - 6 10214 28.8 (2938) 0.75 (0.72, 0.78)
< 3 9152 38.2 (3496) 1
Drug-related conviction ever
Yes 17698 30.0 (5314) 0.92 (0.89, 0.94)
No 29514 32.7 (9657) 1
Sex-related conviction ever
Yes 2902 28.2 (819) 0.88 (0.83, 0.94)
No 44310 31.9 (14152) 1
Cocaine or crack use ever
Yes 15425 36.7 (5667) 1.26 (1.22, 1.29)
No 31787 29.3 (9304) 1
Heroin use ever
Yes 872 39.7 (346) 1.26 (1.16, 1.37)
No 46340 31.6 (14625) 1
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Table 5.3. Associations between HIV test receipt and characteristics of adult
male North Carolina sate prisoners, admitted January 2004 - May 2006 (cont.)
     HIV Tested
n % (n) RR 95% CI
MSM†
Yes 268 38.8 (104) 1.10 (0.95, 1.28)
No 38611 35.3 (13622) 1
Multiple sexual partners†
Yes 8224 29.3 (2410) 0.79 (0.77, 0.82)
No 30655 36.9 (11316) 1
Prostitution†
Yes 2276 37.9 (863) 1.08 (1.02, 1.14)
No 36603 35.1 (12863) 1
Shared needles†
Yes 1163 34.9 (406) 0.99 (0.91, 1.07)
No 37716 35.3 (13320) 1
Blood transfusion†
Yes 277 45.1 (125) 1.28 (1.12, 1.46)
No 38602 35.2 (13601) 1
Mental health‡
Axis I 1107 40.1 (444) 1.28 (1.19, 1.37)
Axis II 1263 34.3 (433) 1.09 (1.01, 1.18)
Neither 44842 31.4 (14094) 1
Hepatitis C
Positive 1485 55.4 (822) 0.89 (0.82, 0.97)
Negative 531 62.0 (329) 1
No test 45196 30.6 (13820)
Syphilis
Positive 1956 39.8 (778) 1.01 (0.95, 1.07)
Negative 33962 39.4 (13380) 1
No test 11294 7.2 (813)
Tuberculosis 
Positive 1797 35.5 (637) 1.12 (1.05, 1.20)
Negative 45415 31.6 (14334) 1
*32.0% (761/2376) of prisoners with missing data were tested for HIV
†14.9% (1245/8333) of prisoners with missing data were tested for HIV
‡Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, 
and dementia; Axis II: personality disorder, developmental disability 
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Table 5.4 Covariate-adjusted associations between HIV test receipt and characteristics of adult 
male and female North Carolina state prisoners, admitted January 2004 - May 2006
        Women           Men
 RR (95% CI) RR (95% CI)
Age group (years)
≥ 45 0.98 (0.95, 1.02) 0.95 (0.91, 0.99)
35 - 44 0.99 (0.96, 1.01) 0.98 (0.94, 1.02)
25 - 34 1.00 (0.97, 1.02) 0.95 (0.91, 0.99)
18 - 24 1 1
Race
Black 0.98 (0.96, 1.00) 0.87 (0.85, 0.90)
Other 0.86 (0.80, 0.93) 0.99 (0.93, 1.05)
White 1 1
Education
College 0.98 (0.95, 1.01) 1.04 (0.99, 1.09)
HS grad or GED 0.99 (0.97, 1.01) 1.05 (1.03, 1.08)
Less than high school 1 1
Employment
Unemployed 1.02 (1.00, 1.04) 0.97 (0.94, 0.99)
Employed 1 1
Marital Status 
Not married or separated 1.03 (1.00, 1.05) 1.02 (0.99, 1.05)
Married 1 1
IQ test result
≤ 80 1.01 (0.98, 1.05) 0.93 (0.90, 0.97)
81 - 100 1.03 (1.01, 1.05) 0.97 (0.95, 1.00)
≥ 101 1 1
Previous time served (months)
None -- 1.06 (1.03, 1.09)
> 0 - 6 -- 1.04 (1.01, 1.08)
7 - 12 -- 1.02 (0.99, 1.06)
≥ 13 -- 1
Drug-related conviction ever† 1.03 (1.01, 1.05) 0.98 (0.96, 1.00)
Sex-related conviction ever† 0.90 (0.81, 1.02) 0.97 (0.92, 1.03)
Heroin use ever† 1.02 (0.98, 1.05) 1.12 (1.05, 1.19)
Cocaine or crack use ever† 1.06 (1.03, 1.08) 1.10 (1.08, 1.13)
Conventional HIV risk behavior‡ -- 1.10 (1.07, 1.13)
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Table 5.4 Covariate-adjusted associations between HIV test receipt and characteristics of adult 
male and female North Carolina state prisoners, admitted January 2004 - May 2006 (cont.)
        Women           Men
 RR (95% CI) RR (95% CI)
Mental health§
Axis I 0.98 (0.94, 1.02) 0.99 (0.93, 1.06)
Axis II 1.00 (0.97, 1.04) 1.05 (0.99, 1.12)
Neither 1 1
Syphilis
Positive -- 1.00 (0.95, 1.05)
Negative -- 1
Tuberculosis 
Positive 0.99 (0.90, 1.10) 1.21 (1.16, 1.26)
Negative 1 1
*model includes variable for intake facilities and covariates with reported estimates
†referent: never
‡includes MSM (men only), multiple sexual partners, prostitution, needle sharing, 
sex with MSM (women only), sex with injection drug user (women only), blood transfusion 1978-1985
§Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, 
and dementia; Axis II: personality disorder, developmental disability 
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Figure 5.1.  Proportion of newly admitted inmates tested for HIV within the two female (F)  
and six male (M) intake facilities of the North Carolina state prison system,   
January 2004 - May 2006     
 
Note: Total intake population in parentheses     
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CHAPTER 6 
CHARACTERISTICS AND BEHAVIORS ASSOCIATED WITH HIV INFECTION IN A 
LARGE SOUTHERN PRISON SYSTEM 
Abstract  
 
Objective:  In a prison system with voluntary HIV testing, identify factors associated with 
testing HIV-positive, and estimate the number of undetected cases 
Methods: Using records of prisoners entering the NC DOC from January 2004 to May 2006, 
associations between HIV serostatus and conventional HIV-risk behaviors, mental health, 
coinfection status, and socio-demographic characteristics were estimated using logistic 
regression. The number of undetected cases was estimated based on age-sex-race specific 
HIV prevalences from tested prisoners and from statewide HIV reporting. 
Results: Nearly 3.4% (718/21,419) of tested prisoners were HIV+.  Among men, infection 
was most strongly associated with MSM (OR=8.0), Black race (OR=6.2), other non-white 
race (OR=7.4), and age group 35-44 years (OR=4.1). The strongest risk factor among women 
was Black race (OR=3.8). Modest associations were observed for several other risk factors 
(ORs < 3.0).  65% of HIV+ prisoners were coinfected with HCV.  We estimated between 
23% (220) and 63% (1215) of HIV cases remained undetected. 
Conclusions:  Modest to moderate associations highlight potential limitations of risk factor 
based HIV testing in prisons. At least one-fourth of all cases may have remained undetected. 
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Background 
 The prevalence of HIV among correctional populations in the US is several times that 
of the general population, and it has been estimated that between 13% and 19% of all HIV-
infected individuals in the US pass through a correctional facility each year.14  The vast 
majority of these infections are acquired in the community.92  Given the limited community 
access to routine healthcare available to prisoners prior to their arrest, prisons are an 
important venue for HIV prevention, testing, and treatment services.13  To facilitate the 
evaluation and improvement of these services, however, it is useful to accurately characterize 
the HIV-infected prison population.   
As of 2005, 27 state prison systems provided voluntary (i.e. consent-based) HIV 
testing, and 7 (~25%) of these systems targeted “high risk” prisoners for testing.29   In the 
wake of the Centers for Disease Control and Prevention’s (CDC) 2003 and 2006 
recommendations to expand the use of routine opt-out HIV testing,47, 95 prison systems which 
traditionally targeted HIV testing at “high risk” inmates now face some pressure to revise 
their testing policies. Moreover, legislation expanding HIV testing in the federal prison 
system is now under consideration.101  Greater understanding of the characteristics of the 
HIV-infected prison population will be helpful to evaluate and improve testing policies. 
Only a few studies have examined characteristics and behaviors of HIV-positive 
prisoners, and most of these studies were conducted in relatively small prison systems in the 
Northeast.  In studies of Connecticut prisoners, for example, Altice et al. reported that HIV-
infection among males was positively associated with injection drug use, psychiatric illness, 
history of a sexually transmitted disease, black race, and Hispanic origin; among female 
prisoners, HIV-infection was associated with injection drug use, sex with a known HIV-
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positive  person, syphilis infection, black race, Hispanic ethnicity, as well as laboratory 
findings of leucopenia and hypoalbuminemia.41, 94  A study of male prisoners in Rhode Island 
found that HIV infection was strongly associated with race and injection drug use,92 and a 
study of Maryland prisoners found that nearly 65% of HIV-infected prisoners were hepatitis 
C (HCV)-infected.102   
Similar studies have rarely been conducted in other parts of the country, including the 
South, which of all US regions has the highest rate of incarceration,103 the greatest number of 
new AIDS diagnoses, and the greatest number of people living with—and dying from—
AIDS.46   
The purpose of this study is to examine associations between HIV-infection and 
socio-demographic characteristics, conventional HIV risk behaviors, drug use, conviction 
history, mental health and coinfections among a population of inmates voluntarily tested for 
HIV in a large southern prison system, the North Carolina Department of Correction (NC 
DOC).  We also use prevalences derived from tested prisoners and those derived from state 
health department data for the entire state to estimate a plausible range of undetected HIV 
cases.  Together, this information could be useful in improving the provision of HIV services 
in prison. 
 
Methods  
The source data are described in detail in an accompanying article (Chapter 5).  In 
brief, the study population included adult prisoners entering the NC DOC between January 1, 
2004 and May 30, 2006 who received a voluntary HIV test anytime during their 
incarceration.  
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When prisoners are incarcerated in the NC DOC, they are first sent to one of eight 
intake prisons and assessed for vocational skill, educational achievement, illicit substance 
use, and mental and physical health.  The medical evaluation includes routine testing for 
syphilis and tuberculosis (TB), and testing for HCV upon clinical indication.  Inmates are 
screened for conventional HIV risk behaviors including: 1) blood transfusion between 1978-
1985, 2) sex with multiple partners, 3) sex as or with a sex worker, 4) needle sharing, 5) sex 
with men (only asked of men), which we refer to as MSM; two behaviors are only assessed 
among women:  6) sex with injection drug users and 7) sex with MSMs.  Following this 
assessment, inmates of unknown serostatus are suppose to have an opportunity to test for 
HIV; inmates self-reporting a previous HIV diagnosis typically receive confirmatory testing 
before initiation of antiretroviral therapy.  Inmates may also receive an HIV test anytime 
during their incarceration upon clinical indication, following an incident with blood 
exposure, such as a fight, and upon their own request.  All HIV-positive inmates are tested 
for HCV.   
Assessments of inmates’ social and criminal histories are conducted by a NC DOC 
case analyst, and are informed by data collected prior to sentencing.  Psychological 
assessments are conducted in several stages, beginning with a 10-item screening instrument. 
Prisoners responding affirmatively to questions on the screener or displaying unusual 
behavior are referred to a psychologist for further evaluation and possible diagnosis based on 
criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV. 
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Electronic records and data linking 
The NC DOC provided electronic records of the data described above.  Dates and 
results of all tests for syphilis, HCV, and HIV conducted during the study period were 
provided in a separate database by Quest Diagnostics, a private company contracted by the 
NC DOC to process diagnostic lab work.   
Electronic prison and lab data were linked using a unique prison identification 
number (PIN) assigned to all inmates upon first admission.  The PIN was present in all prison 
records and missing in less than 3% of lab records.  Lab records with missing PINs were 
excluded from our analyses; only records of prisoners tested for HIV were included for 
analysis.   
Before analysis, each inmate record was assigned a unique study identification 
number, and all other identifying information (names, date of births, and PIN) was removed.  
Only records of inmates 18 years of age or older at the time of prison admission were 
included for analysis.  This project was approved by the Biomedical IRB within The 
University of North Carolina—Chapel Hill and the IRB of The North Carolina Department 
of Corrections.  
 
Coding of infectious disease test results and mental health conditions  
Inmates were classified as HIV-positive if both an enzyme-linked immunosorbent 
assay (ELISA) was reactive and the Western blot was interpreted as positive; HCV-positive 
with a reactive antibody test; and positive for active syphilis if the Rapid Plasma Reagin 
(RPR) titre was 1:8 or  greater.104  All prisoners were assessed for TB using a Montoux 
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screening test at admission.  Since the Montoux results were not electronically available, 
electronic medication prescription data were used:  prisoners prescribed anti-TB medications 
within 30 days of admission were coded as having TB disease. 
Electronic records were used to determine whether prisoners had been diagnosed with 
a mental health disorder within 30 days of admission.  The following diagnoses, based on 
DSM-IV criteria, were included for statistical analysis: (Axis I) psychosis, bipolar disorder, 
major depression, generalized anxiety disorder, dementia, and (Axis II) developmental 
disorders and personality disorders.  Prisoners diagnosed with both Axis I and II diagnosis 
were coded for Axis I only.   
 
Model-based analyses 
The proportion of HIV-infected prisoners was calculated by each of the following: 
socio-demographic characteristics, conventional HIV risk behaviors, drug use, conviction 
history, mental health, TB disease, syphilis infection, and HCV infection. 
Associations between HIV-serostatus and inmate characteristics were evaluated via a 
stepwise model-fitting strategy.  In the first step, for each of the 22 independent variables of 
interest, a gender-specific logistic regression model for the prisoner’s HIV-serostatus (+ or -) 
was fit in a manner which provided a test of size α = 0.05 of the null hypothesis “prevalence 
is invariant across the levels of that independent variable.”  In the second step, a gender-
specific logistic regression model for HIV-serostatus was fit conditional on the inmate 
characteristic of interest and also accounting for other characterics that were statistically 
significant in the first step.   
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Conventional HIV risk behaviors were only recorded for women admitted to one of 
the two intake facilities which process females.  Among men, risk behavior assessments were 
recorded in all but 8% of records.  Prisoners lacking records with the risk behavior 
assessments were excluded from step 2 analyses.   
 
Estimating prevalence of HIV cases among the untested prison population 
Most female prisoners were tested for HIV, but more than two-thirds of male 
prisoners remained untested.  To estimate the number (N) of HIV cases among untested male 
prisoners, we stratified the population of untested males by age (5 categories) and race 
(black, white, other), and multiplied the number (Ni) of untested prisoners within each of 
these strata by corresponding stratum-specific prevalence estimates (^Pi ) obtained  from the 
population of male prisoners tested for HIV.  Thus, the estimate of the number of HIV cases 
( ^N) took the form of a weighted sum of prevalence estimates: 
^N    =   
15
 
i=1
 Σ   
^Pi Ni 
Similarly, 95% confidence intervals were estimated as 
             
^N
  
-/+ 1.96( 15 
i=1
 Σ  Ni2 Vi)1/2 
in which Vi is the stratum specific variance of 
^Pi  derived from the exact confidence intervals.  
Our estimate assumes that the age distribution of untested prisoners was fixed, the variances 
for the prevalence estimates were independent, and that the HIV prevalence among the 
untested population is approximately the same as the prevalance among the tested 
population. 
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 The same approach was repeated using age- and race- specific prevalence estimates   
( ^Pi  ) for the general population of men in North Carolina.  State prevalence estimates among 
men were calculated by dividing the age- and race-specific number of North Carolina men 
known to be living with HIV, as reported to the state health department,90 by the 
corresponding stratum-specific population denominators of men derived from census data.  
For enhanced stability of these state estimates, we pooled HIV case and census data from 
2000-2005.  For estimates based on the state data, Vi was estimated from asymptomtic 
confidence intervals.  All analyses were conducted using SAS vs. 9.1 (Cary, North Carolina).   
 
Results  
During the study period, 54,644 prisoners aged 18 years or older entered the NC 
prison system.  Of these prisoners, we included in our study population the 21,419 (39%) 
prisoners with an HIV test result. 
In table 6.1, characteristics of the HIV-tested population are presented.  About one 
third of the population was female, and nearly half the population was black.  More than 40% 
of males and females did not have a high school degree or GED, and about 60% of males and 
40% of females had been previously imprisoned. More than one-third of men and nearly two-
thirds of women had used crack or cocaine.  Only 1% of males reported having sex with 
males (MSM), but 3% of males and 9% of females reported sharing needles; 17% of females 
also reported sex with men who shared needles.   
Overall, 3.4% (718) of the 21,419 prisoners tested for HIV were positive, including 
3.6% of men and 2.6% of women.  Eighty-four percent of prisoners testing positive had been 
previously diagnosed with HIV in North Carolina.   
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The proportion of male prisoners infected with HIV, by race and age, ranged between 
0 and 9.5%, was greatest among those aged 45-54 years, and was highest among non-whites 
(Table 6.2).  The age- and race-stratified proportions of infected female prisoners generally 
followed the same pattern as the men.  Across ages, blacks comprised 82% of HIV-infected 
males and 75% of HIV-infected females.   
The proportions of HIV-infected prisoners co-infected with TB, syphilis, and HCV, 
were 2.5%, 9.2%, and 67.8%, respectively, and varied little by gender.   
HIV prevalence was greater among those with a history of any conventional HIV risk 
behavior (men: 6.5%, women: 4.0%) compared to those without (men: 2.6%, women: 1.7%), 
but the majority of cases arose from the 79% of males and 57% of females without a history 
of HIV risk behaviors.  Of the 718 HIV cases, 242 (34%) had a history of at least one 
conventional HIV risk behavior, 317 (44%) had no history of any conventional risk 
behaviors, and 159 (22%) had no assessment data.     
Among male prisoners reporting MSM, the proportion infected with HIV was nearly 
30%, and among those who reported either sharing needles or having sex with a sex worker, 
the proportion infected was about 10% (Table 6.3).  Five percent of male cocaine users were 
HIV-positive. Sixty percent of HIV-positive males (293/492) denied all conventional HIV 
risk behaviors.   
In step one of the model-based analyses for men, most of the prisoner characteristics 
variables of interest appeared to be associated with HIV status; exceptions included the 
following: marital status, sex or drug-related conviction, mental health diagnosis, blood 
transfusion history, and TB disease.  
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In step two of the model based analyses for men (Table 6.3), all age groups greater 
than the referent (18-24 years) were associated with greater prevalence of HIV infection, and 
men with the racial categories black (Odds ratio [OR] =6.02, 95% Confidence Interval [CI]: 
4.48, 8.10) and other (OR=7.40, 95% CI: 4.43, 12.36) were more likely than whites to be 
infected.  HIV infection was also more likely among high school (or GED) and college 
graduates than among those who did not complete secondary school; men previously 
incarcerated 7 or more months were at greater risk for infection than those never 
incarcerated.   Heroin use, cocaine/crack use, co-infection with syphilis, and several HIV risk 
behaviors (MSM, multiple partners, sex with prostitutes, and needle sharing) were all 
associated with increased risk of HIV infection (Table 6.3). 
Information for conventional HIV risk behaviors was only collected in one of the two 
female intake facilities.  Among women with available data, 10% reporting sex with a MSM 
partner and 8% reporting blood transfusions prior to 1986 were HIV-positive, but the number 
of cases for each was less than 10.  About 5% of women reporting multiple sexual partners or 
prostitution were HIV-infected (Table 6.4).  Thirty-six percent of HIV-positive women with 
behavioral assessment data (24/67) denied all conventional HIV risk behaviors.   
In the step one of the model-based analyses for women, likelihood of HIV-infection 
was associated with age group 35-44 years, black and other race, unemployment, IQ less than 
100, previous imprisonment, crack/cocaine use, drug crimes, syphilis infection, and HIV risk 
behaviors except for needle-sharing.    
In step two of the model-based analyses for women (Table 6.4), association with age 
was not detected but women with the racial categories black (OR= 4.34, 95% CI: 2.86, 6.59) 
and other (OR= 2.68, 95% CI: 1.02, 7.02) were more likely to be HIV-infected than whites.  
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Crack or cocaine use, drug crime conviction, and 13 or more months previously incarcerated 
were also associated with increased risk for HIV infection, although point estimates for these 
effects were all relatively modest, i.e. OR < 2. 
Hepatitis C testing was limited to about 10% of the study population, but was 
provided to almost all HIV-infected prisoners and to prisoners previously diagnosed with 
HCV.  With such an unrepresentative sample of the population tested for HCV, associations 
between HCV and HIV do not warrant presentation here. 
Based on data of known HIV diagnoses in the state, we estimated that 223 (95% CI: 
220, 225) HIV-infected prisoners remained untested; when this estimate was based on the 
prevalence of HIV among tested prisoners, we estimated 1,101 (95% CI: 987, 1215) HIV-
infected prisoners remained untested.   
 
Discussion 
In an accompanying article, we examined system- and individual-level differences in 
the use of voluntary (i.e. consent-based) HIV testing in the North Carolina state prison 
system.  This article extends those findings by 1) describing the burden of HIV infection 
among tested prisoners, 2) examining individual characteristics and behaviors associated 
with HIV infection among prisoners, and 3) estimating a plausible range of HIV cases among 
the untested prison population. 
As we reported in the accompanying article, 85% of women and 31% of men were 
tested for HIV during the study period (Chapter 5).  Of those inmates, 2.6% of women and 
3.6% of men were HIV-infected. These estimates are greater than prevalence estimates from 
the neighboring state prison system in South Carolina (female: 2.1%, male 2.2%),8 which 
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tests all inmates for HIV.  The estimates are also greater than 6 times those for the general 
NC and US populations (our calculation)105-107. 
Because the vast majority of the female prisoners received an HIV test and there were 
only modest differences in testing across demographic and behavioral characteristics 
(Chapter 5), our estimate of the proportion testing positive, 2.6%, reasonably estimates the 
prevalence in female inmates.  For males, however, elective testing combined with a 
moderate testing rate likely resulted in an estimate of seropositivity unrepresentative of the 
general male prison population.  Supporting this supposition, we previously found large 
differences in testing across intake facilities, which resulted in differences in testing by, 
among other characteristics, race and age (Chapter 5).   
With less than a third of all males tested for HIV, we estimated the number of HIV 
cases among untested male prisoners by assuming that HIV risk was homogeneous within 
race-age category.  Our estimates of undetected HIV cases ranged widely, with the estimate 
based on statewide diagnoses lower than that based on diagnoses in the prison system.  
Nevertheless, this range of estimates provides a useful guide when considering the potential 
public health benefits and the financial costs of expanded HIV testing, as is now 
recommended by the CDC.95  In settings with voluntary HIV testing, this estimation method 
provides a simple and inexpensive alternative to blinded sero-testing as a means to gauge the 
extent of HIV infection.    
In addition to HIV, infectious diseases such as TB, syphilis, hepatitis B, and HCV are 
all common among correctional populations.  Coinfection of these diseases with HIV can 
complicate therapies and lead to greater morbidity and mortality.  Of these infections, HCV 
is typically the most prevalent in correctional populations.14  Untreated HIV/HCV 
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coinfection leads to shorter survival times and greater mortality than HIV-infection alone,108  
and in comparison to HCV-infection alone, coinfection leads to more rapid progression of 
liver fibrosis.  HCV may also exacerbate the side effects of some antiretrovirals used to treat 
HIV, limiting their use.108  National estimates suggest that about 20% of the prison 
population is HCV-infected.14  We found that greater than 65% of HIV-positive prisoners 
were coinfected with HCV, a result similar to that reported among Maryland inmates.102  The 
high prevalence of HCV among HIV-positive prisoners underscores the need to coordinate 
HIV and HCV care, both in prison and after release.   
Among male prisoners, most of the characteristics and behaviors we assessed were 
associated with HIV serostatus, but the majority of these associations were modest in 
magnitude (i.e. OR less than 2). Exceptions included MSM (OR=8.04), and to a lesser 
degree, history of sharing needles (OR=2.14).  Demographic variables age and race were 
moderately associated with HIV infection, with non-whites and those aged 35-44 years at 
greatest risk of infection compared with other inmates.  
Among female prisoners, ORs ranged between 2 and 3 for the associations between 
HIV infection and multiple sexual partners, blood transfusion pre-1986, sex with MSM, and 
drug-related imprisonments.  Black race had the strongest association with HIV status 
(OR=3.57).  In a study of females incarcerated in the Connecticut prison system, Altice et al. 
found that the strongest behavioral risk factors for HIV infection were sex with an HIV-
positive partner (OR=9.1) followed by injection drug use (OR=6.1).  In that population, 
associations between HIV status and other risk factors such as non-injection drug use and 
race were of a similar magnitude to those in our study population; two routine clinical 
laboratory markers, leucopenia (OR=9.4) and hypoalbuminemia (OR=7.2) were also 
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associated with HIV infection among female Connecticut prisoners, but these data may not 
be routinely available in some correctional settings, particularly at intake. 
The goal of targeted testing is to increase the efficiency of case detection.  Seven 
prison systems with voluntary HIV testing services report that they target HIV testing at 
“high risk” inmates, but the specific criteria for testing has not been reported.  In our study 
population, the modest strength of associations for most prisoner characteristics and 
behaviors suggest that targeted testing based on conventional HIV risk behaviors may result 
in limited case finding.  This method of case detection is also reliant upon prisoner’s 
willingness to disclose sensitive behaviors.  Among our study population, greater than half of 
HIV-positive prisoners with a recorded HIV risk assessment failed to disclose any risk 
behaviors.  The high proportion of HIV-positive prisoners coinfected with HCV strongly 
suggests that, at the very least, injection drug use was greatly under-reported.    
Echoing the CDC’s 2006 recommendations, we suggest that testing should be widely 
encouraged among all prisoners, since many are unlikely to disclose risk behaviors.  
Encouragement, however, should not extend into coercion.  As in the community, prisoners 
should maintain their right to accept or decline HIV testing.  It is also imperative that, with 
expanded testing, prison systems provide adequate treatment services and bridge the divide 
between correctional and community healthcare.   In the North Carolina prison system, HIV 
treatment is widely available and programs to bridge correctional and community HIV care 
are currently being expanded.    
This study has a few limitations.  As we have discussed, data specifically designed to 
assess HIV risk were not collected for all prisoners. Risk assessments were not documented 
in one of two intake facilities for women. As a result, more than half of all electronic records 
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among women were missing HIV risk data.  These records, however, corresponded to only 
about 6% of the total study population.   
While most prisoners were assessed for HIV risk behaviors, reluctance to disclose 
risk behaviors likely attenuated the magnitude of associations between risk behaviors and 
HIV status.  And although our data suggests the limited usefulness of targeted HIV testing, a 
more definitive assessment should include construction of receiver operator curves to 
evaluate the potential trade-off between sensitivity and specificity of different risk-factor 
based testing algorithms.  Also, in future investigations, collection of sensitive data could be 
improved using audio computer assisted interviews (ACASI),109 but that was not possible for 
this retrospective investigation.  
Additionally, we were limited to serostatus results among prisoners voluntarily tested 
for HIV.  While our estimate of HIV infection among women was based on testing results 
from the majority of the female prisoners, our estimate for males was based on less than a 
third of the population.  Finally, according to state records, greater than 80% of the 
population testing HIV-positive had an existing HIV diagnosis.  Assuming that most of these 
prisoners disclosed their HIV status in order to prompt confirmatory HIV testing before 
initiating HIV care in prison, our results could have been biased by differential disclosure of 
seropositivity across groups of prisoners.   
Prison systems continue to grapple with HIV testing and treatment in their facilities.  
The increased prevalence of HIV in correctional settings has been demonstrated repeatedly, 
but varies regionally and across different demographic and risk groups.8, 37, 40, 41, 102  This 
study has improved upon existing estimates of HIV burden among inmates in a large prison 
system in the Southeast, and estimates that between 23% and 63% of all HIV cases may be 
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undetected.  With only moderate associations between HIV serostatus and most reported risk 
behaviors, and relatively few prisoners acknowledging behaviors strongly associated with 
infection, testing dependent on prisoners’ disclosure is likely to miss a substantial number of 
HIV infections.  Prison systems predominantly testing “high risk” inmates should re-evaluate 
their testing policies in light of the 2003 and 2006 CDC recommendations.   
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Table 6.1. Characteristics and behaviors of adult inmates tested for HIV 
following incarceration in the North Carolina state prison system,
January 2004 - May 2006
  Women      Men
(N=5,958) (N=15,461)
Age group (years)
45+ 12.2 % 16.5 %
35-44 33.9 31.8
25-34 36.4 36.7
18-24 17.5 15.1
Race
Black 42.8 49.7
Other 3.0 4.7
White 54.2 45.6
Education
College 13.1 8.4
HS degree or GED 46.0 50.3
Less than high school 40.9 41.3
Unemployed* 66.5 31.3
Married* 15.1 15.5
IQ test results
≤ 80 13.7 21.4
81 - 100 55.0 55.2
≥ 101 31.4 23.3
Previous time served (months)
None 57.8 36.8
> 0 - 6 15.8 15.1
7 - 12 11.3 10.9
≥ 13 15.2 37.3
Sentence length (months)†
≥ 19  14.5 29.4
7 - 18 23.1 25.5
3 - 6 31.8 20.7
< 3 30.7 24.4
Drug-related conviction ever 41.8 35.6
Sex-related conviction ever 1.2 5.5
Cocaine or crack ever 64.9 38.4
Heroin ever 6.1 2.4
Same-sex sexual partner‡ 15.2 1.0
Multiple sexual partners‡ 27.1 18.0
Prostitution‡ 16.7 6.8
Share Needles‡ 9.4 3.2
Blood transfusion‡ 2.9 0.9
Sex with Needle Sharer§ 16.2 --
Sex with MSM§ 3.2 --
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Table 6.1. Characteristics and behaviors of adult inmates tested for HIV 
following incarceration in the North Carolina state prison system,
January 2004 - May 2006 (cont.)
  Women      Men
Age (N=5,958) (N=15,461)
Mental health\
Axis I 6.4 3.0
Axis II 4.6 2.9
Hepatitis C
Positive 9.4 7.5
Negative 2.7 3.1
No test 87.9 89.4
Syphilis
Positive 5.9 5.3
Negative 93.5 89.4
No test 0.6 5.3
Tuberculosis 1.0 4.2
*Data missing for ≤ 5 observations per gender
† Data missing for 421 (7% of) women and 778 (5% of) men
‡Data not collected from 59% of women and 9% of men
§Data not collected from 59% of women and all men
\Axis I: psychosis, bipolar disorder, major depression, generalized anxiety, 
and dementia; Axis II: personality disorder, developmental disability 
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Table 6.2. HIV test results by age, race, and sex of adult inmates entering the North Carolina state 
prison system, January 2004 - May 2006
Black Other White
         HIV+          HIV+          HIV+
Age Total % (n) Total % (n) Total % (n)
Male 55+ 203 6.9 (14) 3 0.0 (0) 124 0.0 (0)
45-54 1275 9.5 (121) 56 5.4 (3) 885 1.1 (10)
35-44 2513 8.2 (206) 178 5.6 (10) 2226 1.4 (31)
25-34 2592 4.0 (103) 356 3.9 (14) 2720 1.0 (26)
18-24 1098 1.7 (19) 138 2.2 (3) 1094 0.2 (2)
Total 7681 6.0 (463) 731 4.1 (30) 7049 1.0 (69)
Female 55+ 33 6.1 (2) 0 36 2.8 (1)
45-54 307 4.2 (13) 15 6.7 (1) 338 0.9 (3)
35-44 913 6.5 (59) 64 4.7 (3) 1045 1.8 (19)
25-34 846 3.7 (31) 79 1.3 (1) 1241 0.6 (8)
18-24 449 2.7 (12) 23 0.0 (0) 569 0.5 (3)
Total 2548 4.6 (117) 181 2.8 (5) 3229 1.1 (34)
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Table 6.3. Covariate-adjusted associations between characteristics of adult male 
North Carolina state prisoners and HIV infection, January 2004 - May 2006
     HIV-positive        Adjusted
n % (n) OR 95% CITotal Total
Age group (years)
45+ 2546 5.8 (148) 3.88 (2.30, 6.54)
35-44 4917 5.0 (247) 4.07 (2.46, 6.74)
25-34 5668 2.5 (143) 2.63 (1.59, 4.37)
18-24 2330 1.0 (24) 1
Race
Black 7681 6.0 (463) 6.21 (4.60, 8.41)
Other 731 4.1 (30) 7.36 (4.36, 12.42)
White 7049 1.0 (69) 1
Education
College 1294 4.9 (64) 1.45 (1.01, 2.08)
HS grad or GED 7776 3.7 (284) 1.28 (1.02, 1.59)
Less than high school 6391 3.3 (214) 1
Employment
Unemployed 4836 5.8 (279) 1.68 (1.37, 2.06)
Employed 10620 2.7 (283) 1
Marital Status 
Not married/separated 13071 3.8 (491) 1.21 (0.89, 1.63)
Married 2388 3.0 (71) 1
IQ test (Beta)
≤ 80 3312 5.8 (193) 1.83 (1.30, 2.57)
81 - 100 8540 3.5 (299) 1.21 (0.89, 1.63)
≥ 101 3609 1.9 (70) 1
Previous time served (months)
≥ 13 5765 5.7 (326) 1.84 (1.39, 2.44)
7-12 1680 3.4 (57) 1.46 (1.01, 2.13)
≤ 6 2330 3.0 (70) 1.11 (0.76, 1.61)
None 5686 1.9 (109) 1
Sentence length (months)
≥ 19  4311 4.0 (172) 1.74 (1.31, 2.32)
7 - 18 3745 4.0 (150) 1.81 (1.36, 2.42)
3 - 6 3044 4.0 (121) 1.96 (1.45, 2.65)
< 3 3583 2.8 (99) 1
Heroin
Yes 369 6.8 (25) 1.80 (1.07, 3.02)
No 15092 3.6 (537) 1
Cocaine or crack
Yes 5932 5.0 (298) 1.30 (1.06, 1.60)
No 9529 2.8 (264) 1
MSM
Yes 144 29.9 (43) 8.04 (5.17, 12.51)
No 14008 3.2 (446) 1
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Table 6.3. Covariate-adjusted associations between characteristics of adult male 
North Carolina state prisoners and HIV infection, January 2004 - May 2006 (cont.)
     HIV-positive        Adjusted
n % (n) OR 95% CITotal Total Total
Multiple sexual partners
Yes 2548 5.9 (150) 1.41 (1.08, 1.84)
No 11604 2.9 (339) 1
Prostitution
Yes 961 10.7 (103) 1.64 (1.20, 2.24)
No 13191 2.9 (386) 1
Shared needles
Yes 447 9.4 (42) 2.14 (1.38, 3.31)
No 13705 3.3 (447) 1
Blood transfusion
Yes 130 3.8 (5) 0.40 (0.15, 1.07)
No 14022 3.5 (484) 1
Sex-related conviction ever
Yes 846 3.5 (30) 0.86 (0.53, 1.41)
No 14615 3.6 (532) 1
Drug-related conviction ever
Yes 5503 4.0 (219) 0.79 (0.64, 0.98)
No 9958 3.4 (343) 1
Mental health*
Axis I 465 4.9 (23) 1.17 (0.65, 2.10)
Axis II 453 5.1 (23) 1.60 (0.96, 2.66)
Neither 14543 3.5 (516) 1
Hepatitis C
Positive 1161 33.2 (385) --
Negative 473 34.7 (164) --
Syphilis
Positive 816 6.3 (51) 1.50 (1.05, 2.13)
Negative 13823 3.6 (498) 1
Tuberculosis 
Yes 650 2.3 (15) 0.42 (0.22, 0.80)
No 14811 3.7 (547) 1
*Axis I: psychosis, bipolar disorder, major depression, generalized anxiety, 
and dementia; Axis II: personality disorder, developmental disability 
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Table 6.4. Covariate-adjusted associations between characteristics of adult female 
North Carolina state prisoners  and HIV infection, January 2004 - May 2006
   HIV-positive         Adjusted
n % (n) OR 95% CITotal
Age group (years)
45+ 729 2.74 (20) 1.78 (0.44, 7.15)
35-44 2022 4.01 (81) 2.55 (0.73, 8.86)
25-34 2166 1.85 (40) 1.97 (0.56, 6.97)
18-24 1041 1.44 (15) 1
Race
Black 2548 4.59 (117) 3.57 (1.89, 6.73)
Other 181 2.76 (5) 2.38 (0.53, 10.74)
White 3229 1.05 (34) 1
Education
College 780 2.18 (17) --
HS degree or GED 2742 2.48 (68) --
Less than high school 2436 2.91 (71) --
Employment
Unemployed 3962 2.98 (118) 1.50 (0.78, 2.87)
Employed 1994 1.91 (38)
Marital Status 
Not married/separated 5057 2.71 (137) 0.75 (0.37, 1.54)
Married 901 2.11 (19)
IQ test (Beta)
≤ 80 813 4.67 (38) 2.00 (0.86, 4.68)
81 - 100 3276 2.72 (89) 1.33 (0.64, 2.79)
≥ 101 1869 1.55 (29) 1
Previous time served (months)
≥ 13 904 4.87 (44) 1.01 (0.49, 2.09)
7-12 670 3.88 (26) 0.98 (0.44, 2.17)
≤ 6 942 2.34 (22) 0.61 (0.28, 1.36)
None 3442 1.9 (64) 1
Sentence length (months)
≥ 19  803 3.11 (25) --
7 - 18 1277 2.51 (32) --
3 - 6 1758 2.45 (43) --
< 3 1699 2.71 (46) --
Heroin use ever
Yes 366 3.55 (13) 0.50 (0.11, 2.19)
No 5592 2.56 (143) 1
Cocaine or crack use ever
Yes 3869 3.33 (129) 1.21 (0.59, 2.50)
No 2089 1.29 (27) 1
Multiple sexual partners
Yes 666 4.95 (33) 2.16 (1.13, 4.14)
No 1788 1.90 (34) 1
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Table 6.4. Covariate-adjusted associations between characteristics of adult female
North Carolina state prisoners  and HIV infection, January 2004 - May 2006 (cont.)
   HIV-positive         Adjusted
n % (n) OR 95% CI
Prostitution
Yes 410 5.61 (23) 0.93 (0.46, 1.86)
No 2044 2.15 (44) 1
Shared needles
Yes 231 3.46 (8) 1.04 (0.42, 2.54)
No 2223 2.65 (59) 1
Blood transfusion
Yes 71 8.45 (6) 2.64 (1.02, 6.81)
No 2383 2.56 (61) 1
Sex with Needle Sharer
Yes 397 4.03 (16) 1.38 (0.63, 3.01)
No 2057 2.48 (51) 1
Sex with MSM
Yes 79 10.13 (8) 2.21 (0.85, 5.73)
No 2375 2.48 (59) 1
Sex-related conviction ever
Yes 71 2.82 (2) --
No 5887 2.62 (154) --
Drug-related conviction ever
Yes 2488 3.58 (89) 2.13 (1.21, 3.75)
No 3470 1.93 (67) 1
Mental health*
Axis I 379 3.69 (14) 1.83 (0.72, 4.69)
Axis II 272 1.10 (3) 0.68 (0.09, 5.23)
Neither 5307 2.62 (139) 1
Hepatitis C
Positive 557 18.31 (102) --
Negative 162 29.01 (47) --
Syphilis
Positive 352 4.26 (15) 1.33 (0.55, 3.25)
Negative 5573 2.49 (139) 1
Tuberculosis 
Positive 57 5.26 (3) --
Negative 5901 2.59 (153) --
*Axis I: psychosis, bipolar disorder, major depression, generalized anxiety, 
and dementia; Axis II: personality disorder, developmental disability 
  
CHAPTER 7 
DISCUSSION 
The importance of prisons in detecting and providing care for HIV-positive inmates 
has been well known for nearly twenty years.51-54  Despite this recognition by public health 
practitioners and correctional medical personnel, efforts to systematically evaluate the 
provision of HIV-services in correctional settings have been quite limited.  This dissertation 
assessed voluntary (i.e. consent-based) HIV testing services in the North Carolina state 
prison system. In addition to expanding our understanding of HIV services in the North 
Carolina system, this assessment provides a useful model for research and evaluations in 
other prison systems.    
To begin the assessment process, I reviewed the existing literature addressing 
mandatory and consent-based HIV testing services in state prison systems.  I then identified 
key research areas relevant to consent-based testing.  Focusing on a few of these areas, I 
defined specific research questions to better understand the delivery of voluntary testing 
services and following institutional approval, obtained relevant data from the NC prison 
system and the state health department.  The analyses of these data describe inmate HIV 
testing between the years 2004-2006 in the North Carolina prison system and provide 
recommendations to improve testing services.   
The Chapter 3 literature review, published in Infectious Diseases in Corrections 
Report,93 describes the heavy burden of HIV among correctional populations and provides a 
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discussion of the three major HIV testing policies currently implemented in state prison 
systems across the US:  mandatory testing, voluntary opt-in testing, and voluntary opt-out 
(routine) testing.  The rationale and consequences of each of these policies are explored both 
from the perspective of the individual prisoner and from the utilitarian perspective of 
preventing the greatest number of HIV infections.  The conclusion outlines several research 
areas that could inform the provision of voluntary HIV testing services in correctional 
settings:  
1. Describe HIV testing coverage across the entire prison system, within each intake 
prison, and among high risk groups of prisoners. 
2. Assess congruity between testing policies and their applications. 
3. Examine inmate and system characteristics associated with uptake of HIV testing  
4. Assess the role of the nurse-counselor in acceptance of testing. 
5. Determine the roles of confidentiality and stigma in the acceptance of testing. 
6. Evaluate the efficacy of counseling on the acceptance of HIV testing and the 
reduction of inmate risk behaviors. 
7. Document psychosocial and physical (e.g. disease-related morbidity, target of assault) 
consequences of testing positive in prison. 
8. Estimate costs of HIV testing, counseling, and prevention programs in prison. 
9. Evaluate availability of and access to services following release of HIV-infected 
prisoners. 
 
Of these research areas, the analytic portion of the dissertation focuses on the first 
three items since these address questions central to voluntary testing services and could be 
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approached with existing data and financial resources.  Grant funds have recently been 
awarded to conduct additional research projects, including studies initially proposed as part 
of this dissertation, to address other research priorities outlined above. Grant funded projects 
are described below in the section Future Research.   
Chapters 5 and 6 provide the results from two analyses of voluntary HIV testing.  
Together, the analyses focused on four aims.  Below, each aim is presented with a hypothesis 
(or expected result) followed by a summary of the findings. 
 
Specific Aims and Findings 
Specific Aim 1. Determine system-wide and facility-specific HIV testing rates among 
inmates without a pre-existing HIV diagnosis, in a state prison system with voluntary HIV 
testing 
Hypothesis: Rate of HIV testing varies from one prison entrance facility to another.  
Findings:  
• Approximately 40% of prisoners were tested for HIV. 
• Most prisoners tested for HIV were tested at an intake prison as part of the admission 
process. 
• In the two intake prisons for women, HIV testing was provided routinely (i.e. opt-
out), and testing rates were greater than 80%. 
• In the six intake prisons for men, opt-in HIV testing was available; rates in the intake 
prisons ranged between 1-47%.   
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Specific Aim 2.  Identify inmate characteristics associated with receipt of an HIV test among 
inmates without a pre-existing HIV diagnosis  
 
Hypotheses: HIV testing is positively associated with greater number of prior incarcerations 
and history of behavioral risk factors; testing is negatively associated with history of mental 
health condition and African American race. 
Findings: 
• Demographic differences across intake populations and differences in intake testing 
rates contributed to differential testing by demographic characteristics. 
• Among males, non-whites were between 30%-40% less likely than whites to be tested 
for HIV. 
• There was at least a 10% increase in testing among males disclosing conventional 
HIV risk behaviors, but most of these prisoners were not tested. 
• First-time prisoners were more likely than recidivists to be tested for HIV, but the 
difference was very modest. 
• Inmates with a DSM Axis II mental health condition were slightly more likely to be 
tested than those with no diagnosis, but this difference was small; there was no 
relationship between testing and an Axis I diagnosis.   
 
Specific Aim 3. Identify inmate characteristics associated with HIV serostatus  
Hypotheses: HIV infection is positively associated with African American race, female 
gender, older age, history of behavioral risk factors, history of mental health condition, and 
greater number of prior incarcerations. 
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Findings: 
• 3.4% of prisoners (2.6% of women, 3.6% of males) tested for HIV were infected.   
• Greater than 80% of prisoners with a positive HIV test had been previously diagnosed 
with HIV in North Carolina. 
• Black men aged 45-54 years had the highest HIV prevalence of any demographic 
group (9.5%). 
• Non-white males were 6-7 times as likely as whites to be HIV-infected. 
• Less than 1% of males tested for HIV reported same-sex sexual activity, but of these, 
about 30% were HIV-infected.  
• About 10% of males reporting needle sharing or intercourse with a sex-worker were 
HIV-infected. 
• Ten percent of women reporting sex with a MSM partner and 8% reporting blood 
transfusions prior to 1986 were HIV-positive, but the number of cases for each was 
fewer than 10. 
• Five percent of women reporting multiple sexual partners or prostitution were HIV-
infected.  
• Greater than two-thirds of HIV-positive prisoners were coinfected with hepatitis C. 
• Syphilis was twice as common among HIV-positive prisoners. 
 
Specific Aim 4. Estimate the number of HIV-infected prisoners who remain untested in the 
North Carolina prison system 
Hypothesis: At any given time, at least one-third of existing HIV cases among prisoners will 
remain undetected. 
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Finding: Greater than 25% of HIV-infected prisoners remain undetected (i.e. untested).  This 
result assumes that the rate among untested prisoners is at least as large as the rate among 
tested prisoners.  This assumption has not been verified.   
 
Data Concerns 
 To my knowledge, this dissertation constitutes the largest study of voluntary HIV 
testing among US prisoners.  Inclusion of such a large study population (~53,000) would not 
have been possible without the use of existing administrative and lab data from the NC DOC 
and Quest diagnostics, a private company contracted by the prison system to process 
diagnostic lab work.  However, use of existing data did present some challenges.     
Although most of the administrative data from the NC DOC were available, HIV risk 
assessment data were not collected in one of the two intake prisons for women. These 
missing data corresponded to a relatively small proportion of all prisoners in the study 
population, but did affect greater than half of all female prisoners. As a result of these 
missing data, the number of women who could be included in the multivariable regression 
analyses, for both testing and serostatus, was severely reduced.  Among the men, about 18% 
of data describing HIV risk behaviors were missing.  To assess potential selection bias due to 
exclusion of subjects with incomplete data, I conducted an analysis which relied on multiple 
imputation, and then compared the results to those from a complete case analysis.  These 
results were also compared to an analysis restricted to inmates who entered the three intake 
prisons with less than 2% missing HIV behavioral data. There were no important differences 
in the results from the three analyses (see Appendix Table 6.5).   
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In addition to problems caused by missing data, it was not possible to validate the 
existing data.  Validation is of particular concern for the HIV behavioral data since prisoners 
may have been reluctant to disclose stigmatizing and, in some cases, illegal behaviors.  
Indeed, it appears that these behaviors were under-reported.  For example, with most HCV 
infections acquired percutaneously,108 the high rate of HCV infection among the HIV-
positive population suggests that needle sharing was not limited to the 9% of HIV+ prisoners 
who disclosed this behavior.  Similarly, the low frequency of MSM behaviors reported by 
prisoners as compared to that reported by community populations, suggest that this behavior 
was also under-reported.  Under-reporting of these conventional HIV risk behaviors 
attenuated their associations with both HIV testing and HIV serostatus.   
There were also some issues specific to the Quest lab data.  Data requests for research 
are uncommon at Quest, and several iterations were necessary before the data managers at 
Quest compiled the desired database.  Once the database was compiled, it was evident that 
the unique prison identification number was not consistently included in lab records before 
2004 so it was necessary to limit the study period to 2004-2006.  Initial examination of the 
daily frequency of labs (HIV, HCV, syphilis) for the years 2004-2006 indicated that data 
were missing for a few discrete time periods.  Quest provided data for those missing periods, 
but ultimately it was not possible to verify whether other lab data were inadvertently omitted. 
Of some reassurance, the frequency of labs documented in the Quest database was consistent 
with a preliminary analysis of aggregate data from each of the intake facilities.       
Finally, we were unable to link a small proportion of lab records (3%) to prison 
records.  It is not possible to determine if these unlinked lab records correspond to inmates in 
our study population; it’s possible that some unlinked records corresponded to inmates who 
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were incarcerated during the study period, but were excluded because they entered prison 
before the study period began. 
 
Discussion and recommendations 
In the Chapter 3 literature review, I examined different approaches to HIV testing, 
namely voluntary opt-in testing, routine opt-out testing, and mandatory testing.  As explained 
in the chapter, CDC, World Health Organization, and American Public Health Association 
all advocate that HIV testing of prisoners should be consent-based.  The position of these 
groups is that basic human rights must be preserved for prisoners, and among these rights is 
the freedom to make autonomous medical decisions such as HIV testing.  Echoing this 
position, I recommend that HIV testing remain consent-based in the NC DOC to preserve 
inmates’ rights as well as to reflect community practice.  
The nature of HIV testing in the community, however, is changing.  In September 
2006, the CDC released revised HIV testing recommendations. The new recommendations, 
which are applicable to a variety of health care settings including correctional facilities, call 
for routine opt-out HIV testing, in which testing is to be provided as a standard part of 
medical care; patients are notified that they will be tested unless they explicitly decline.  In 
contrast to past recommendations, pre-test counseling and informed consent are no longer 
required. (For persons with a confirmed positive test result, post-test counseling and referral 
are still recommended.)   Despite the new recommendations, financial concerns, issues of 
confidentiality, and in some states, existing legislation mandating pre-test counseling have all 
slowed the transition to routine-opt out testing.110, 111  Prison systems, including the NC 
DOC, should follow the lead of their individual states as they transition to opt-out testing.   
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As expected from a preliminary analysis, HIV testing varied greatly across intake 
prison.  Testing rates were high in the two intake prisons for females, but lower and more 
variable among the six intake prisons for men.   High rates of testing in the prisons for 
women were due to the implementation of opt-out testing, which was provided as a 
component of reproductive health evaluations.  Similar testing rates have been described in 
the Rhode Island state prison system, which conducts opt-out testing for both men and 
women.59   
According to informal interviews of key informants, differences in testing rates across 
intake prisons for men were in part explained by differing priorities amongst the chief 
medical administrator at each facility.  A formal evaluation of the relationship between 
organizational structure and HIV testing could yield other useful insights.  In a national 
sample of correctional facilities, Oser et al. found few relationships between components of 
facility organizational structure and the availability of HIV testing services.97  Despite 
national guidelines for correctional health services established by the National Commission 
on Correctional Health, factors determining testing policy may be idiosyncratic to each state 
prison system.   Therefore, it may be more productive to conduct future analyses within, 
rather than across, state prison systems.   
Regardless of the forces shaping HIV testing policy, it is evident that the vague 
system-wide testing policy in the NC DOC has been implemented differently across intake 
prisons.  HIV testing services in NC DOC should be unified across intake prisons, and the 
provision of services should be defined by a clear, rational, and equitable policy.  Moreover, 
testing rates should be reflective of testing among other populations in high risk settings.  If, 
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as recommended by the CDC, HIV testing expands in community settings, similar expansion 
of testing services would be appropriate for correctional populations.    
In Chapter 5, I found that the vast majority of all HIV tests were conducted at intake.  
Testing after intake accounted for only about 6% of all HIV-tests.  Most female prisoners are 
tested for HIV, and their sentences tend to be brief, so it is not necessary to expand testing for 
this population.  On the other hand, more than 60% of male prisoners are never tested for 
HIV.  Providing periodic opportunities for male prisoners to be offered testing could increase 
uptake.  Considering that male prisoners are sentenced for a median of 12 months, I 
recommend that HIV testing be offered at six month intervals across all 76 prisons.  Those 
without an HIV test in the preceding six months would be eligible.  Periodic offers of testing 
could not only increase overall acceptance of testing, but repeat testing of prisoners tested at 
admission could be useful in monitoring intra-prison transmission.91   
In the Chapter 5 analyses, I also examined the association between individual 
characteristics and HIV testing after controlling for testing differences across intake prison.  
Based on the existing literature, I hypothesized that HIV testing is positively associated with 
greater number of prior incarcerations and history of behavioral risk factors, and is negatively 
associated with history of mental health condition and black race.  Of these hypotheses, those 
for behavioral risk factors and race were correct, but those for incarceration history and 
mental health were not supported.   
First-time prisoners were more likely than recidivists to be tested for HIV, but the 
difference was modest.  Since many prisoners are tested for HIV, it may be that recidivists 
were more likely to have previously received a negative test, and therefore felt little incentive 
to be tested again, regardless of their time since testing.  My rationale for the original 
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hypothesis was that prisoners would be more accepting of HIV testing upon repeated entry 
because they would have more familiarity with the prison system, but of course the opposite 
could also be true: recidivists could be less trusting of medical services in prison as compared 
to first-time prisoners.    
The interest in mental health and HIV testing originated from several studies that 
indicate that serious mental health problems are associated with increased risk of HIV, and 
other studies indicating that increased risk of infection was associated with decreased testing 
rates.   
In our data, selected Axis I and Axis II mental conditions were associated with an 
increased risk of HIV, but these associations were modest and did not remain statistically 
significant after controlling for other covariates.  These results differ from a study by Altice 
et al., which found significant associations between mental health conditions and HIV-
infection, but that study included a much broader spectrum of disorders in its definition of 
mental health condition.41  Inmates with a DSM Axis II mental health condition, which 
includes personality disorders and developmental disabilities, were slightly more likely to be 
tested for HIV than those with no diagnosis, but this difference was small.  There was no 
relationship between testing and an Axis I diagnosis.   
Among males, HIV testing varied by race, with blacks less likely to be tested than 
whites.  In part, this finding is a consequence of large populations of black males in the 
intake facilities with the lowest overall testing rates.  Nevertheless, even after controlling for 
intake facility, black males were about 13% less likely than white males to be tested for HIV.  
This is concerning in the context of the much higher HIV prevalence in black men nationally, 
in North Carolina, and among tested prisoners (Chapter 6).  Among both men and women, 
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race was one of the strongest predictors of HIV infection, and both blacks and “others” were 
more likely to be infected than whites.  I note, however, that these racial disparities are 
attenuated compared to infection rates in the state, in which black men and women, 
respectively, are 7 and 16 times as likely as white men and women to be infected with HIV.   
Adjusting for testing differences across intake prisons, high risk behaviors were 
associated with about a 10% increase in the rate of testing.  At the same time, a high 
proportion of those disclosing conventional HIV risk behaviors were likely to be infected, but 
the frequency of disclosure for most of these behaviors was uncommon.  In the most extreme 
example, 30% of males disclosing MSM behaviors were infected with HIV.  However, very 
few prisoners disclosed these potentially stigmatizing behaviors, and the adjusted relative 
risk for other conventional HIV risk behaviors was modest.    
In fact, greater than half of all HIV-positive prisoners were without documentation of 
conventional HIV risk behaviors.  This finding suggests that prisoners, regardless of 
documented risk history, should be offered the opportunity to be tested for HIV.   However, 
it is important to put in place safeguards so that decisions to be tested are autonomous 
choices and not the result of coercion or misperceptions that testing is mandatory.  Such 
safeguards could include periodic focus groups conducted by outside organizations, which 
explore prisoners’ perspectives of the HIV testing process, without eliciting individual 
reasons for opting in or out of testing.   
Another potential explanation for the large number of HIV diagnoses not linked to 
documented risk behavior is the possibility that, upon prison entry, these inmates were aware 
of their serostatus from prior testing.  It is possible that nurse-counselors did not document 
risk behaviors for prisoners disclosing their positive HIV-serostatus upon entry.  However, if 
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risk assessments were skipped for this population, it is more likely that these data would be 
missing rather than coded to indicate an absence of risk behavior history.   
 Finally, prison systems are struggling to find an appropriate response to HCV.  HCV 
is common among prisoners and its sequalae can lead to hepatic cancer, but such outcomes 
are rare, and the treatment is both difficult to tolerate and expensive.  As a result, many 
prison systems have been reluctant to screen for HCV.  For HIV-infected prisoners, HCV is 
particularly relevant because it can limit antiretroviral HIV medication options and lead to 
worse outcomes. My findings demonstrate that the HIV-infected population is being 
appropriately screened for HCV.  The next step in evaluation is to ensure that there is proper 
coordination of treatment services for co-infected prisoners.    
 
Summary of recommendations 
1. To reflect community practice, HIV testing should remain consent-based  
2. Safeguards are necessary to ensure that testing is not coercive 
3. HIV testing policy and practice should be unified across intake facilities   
4. Testing should be widely available and encouraged among prisoners disclosing no 
risk behaviors 
5. Testing should be periodically offered to male prisoners 
6. Testing history should be documented in prisoners’ medical records 
7. Linkages between HIV care and care for other coinfections, particularly hepatitis C, 
should be strengthened 
A few other recommendations are derived from the literature.  In a study assessing 
provider perspectives of HIV testing in prisons across 4 states, many reported that negative 
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test results were often not reported to inmates.112  Report of negative test results could be 
facilitated using rapid testing.  Though not addressed in my results, rapid testing should be 
considered.     
Others have recommended that prison systems with HIV testing must also provide 
comprehensive medical treatment and programs which effectively bridge correctional and 
community care.15  In the North Carolina prison system, these conditions are being met.  HIV 
treatment is widely available and is supported by three infectious disease clinics and a team 
of mobile nurses dedicated exclusively to providing HIV care throughout the prison system.  
A program to enhance continuity of care has been piloted in the North Carolina prison 
system, and with its success, has now been expanded to provide services to most HIV-
infected prisoners as they transition from the NC DOC back to their communities.   
 
Future Research Directions 
In this dissertation, I examined risk factors associated with HIV test receipt and, 
among those voluntarily tested for HIV, risk factors associated with seropositivity.  These 
results provided information about groups of prisoners who were at increased risk of HIV 
infection and groups of prisoners at decreased likelihood of testing; however, our analyses 
did not include serostatus data for those prisoners who declined testing. 
Recently a large grant was awarded by that National Institute of Mental Health to 
build upon the research presented in this dissertation.  A blinded seroprevalence study is 
planned to examine the relationship between infection status and prisoners’ behavioral risk 
factors, demographic characteristics, and decision to accept/decline voluntary testing.  This 
study will provide a clearer characterization of the population of HIV-infected prisoners who 
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decline testing.  This serosurvey will also provide unbiased estimates of HIV prevalence and 
an estimate of the number of HIV cases declining HIV testing.  This latter estimate will 
inform the utility of the method I used to estimate undetected cases.   
Studies to investigate barriers and facilitators to HIV testing in correctional settings 
are also planned.  In-depth interviews will be conducted with both prisoners and the nurse-
counselors who provide HIV testing services.  Psychosocial (perceptual) factors associated 
with testing can be conceptualized using theoretical models of health behavior.  Explicit use 
of these models helps organize relevant constructs and provides a systematic framework for 
advancing both empirical and theoretical work aimed at understanding HIV testing.  Specific 
constructs to be measured will be formulated based on data from in-depth interviews, but will 
likely include the following constructs derived in part from the Health Belief Model and the 
Theory of Planned Behavior: risk of HIV acquisition, severity of HIV-infection, social 
repercussions of infection, benefit of testing, perceived testing barriers, social norms, actual 
testing barriers, imprisonment history, and HIV test experience.  Similar interviews with 
providers are also planned to determine their influence on the HIV testing process.   
Another important area of study is the consequences of an HIV diagnosis in prison.  
Anecdotal evidence and individual lawsuits brought by HIV-infected prisoners incarcerated 
outside of the North Carolina prison system suggest that an HIV diagnosis may result in 
discrimination and harassment from both correctional staff and other prisoners.  To explore 
this issue, administrative data will be used to conduct a retrospective study examining the 
association between HIV serostatus and indicators of harassment such as physical trauma and 
administrative punishments.   
 104 
In addition to the funded studies described above, research is needed to determine the 
effectiveness of HIV-counseling and testing on the reduction of risk behaviors following 
inmates’ release.  The preventative effect of these services is questionable given the lag 
between counseling and testing at entry and inmates’ release several months, if not years, 
later.  After the restrictions of prison life, inmates may be particularly recalcitrant to 
prevention messages as they reestablish their sexual lives in the community.  Better 
estimation of the preventive effect of counseling and testing among inmates would improve 
cost-benefit analyses of HIV-testing among this population.   
 
 
Concluding thoughts 
 
Beginning in the late 1970’s and continuing for the next two decades, the US prison 
population experienced tremendous growth.  With the expansion and aging of correctional 
populations, prisons have become an increasingly important source of health care in the US.  
The eventual return of most prisoners to the community suggests that prisons also have an 
important public health role.  This role is particularly relevant for detecting and treating 
infectious diseases such as HIV.  The potential of that role, however, cannot be achieved 
without systematic evaluation of services.  The will to conduct these evaluations must come 
from the state legislature and medical administrators in departments of corrections, as in 
North Carolina.  Departments of corrections not equipped to conduct service evaluations can 
benefit from collaborations with outside organizations, such as academic centers, state and 
county health departments, and non-profit organizations with research capabilities.  Aside 
from providing skills and resources to conduct evaluations, these collaborations are an 
important step in bridging the divide between prison and community health services.   
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APPENDIX 
 
Table 5.5 Comparison of complete case, multiple imputation, and restricted population multivariate analyses
of HIV testing among adult males admitted to the North Carolina Department of Corrections, 
January 2004 - May 2006\
Complete Case Multiple Imputation Restricted population
RR (95% CI) RR (95% CI) RR (95% CI)
Age group (years)
≥ 45 0.95 (0.91, 0.99) 0.94 (0.90, 0.99) 0.96 (0.91, 1.00)
35 - 44 0.98 (0.94, 1.02) 0.99 (0.94, 1.03) 0.98 (0.94, 1.02)
25 - 34 0.95 (0.91, 0.99) 0.96 (0.92, 1.00) 0.95 (0.91, 0.99)
18 - 24 1 1 1
Race
Black 0.87 (0.85, 0.90) 0.85 (0.83, 0.87) 0.88 (0.85, 0.90)
Other 0.99 (0.93, 1.05) 0.78 (0.73, 0.83) 1.00 (0.94, 1.06)
White 1 1 1
Education
College 1.04 (0.99, 1.09) 1.04 (0.99, 1.09) 1.02 (0.97, 1.07)
HS degree or GED 1.05 (1.03, 1.08) 1.05 (1.02, 1.08) 1.04 (1.02, 1.07)
Less than high school 1 1 1
Employment
Unemployed 0.97 (0.94, 0.99) 0.97 (0.94, 1.00) 0.96 (0.94, 0.99)
Employed 1 1 1
Marital Status 
Not married or separated 1.02 (0.99, 1.05) 1.05 (1.01, 1.08) 1.03 (0.99, 1.06)
Married 1 1 1
IQ test result
≤ 80 0.93 (0.90, 0.97) 0.92 (0.88, 0.96) 0.92 (0.89, 0.96)
81 - 100 0.97 (0.95, 1.00) 0.99 (0.96, 1.02) 0.97 (0.95, 1.00)
≥ 101 1 1 1
Previous time served (months)
None 1.06 (1.03, 1.09) 0.91 (0.88, 0.93) 1.06 (1.03, 1.09)
> 0 - 6 1.04 (1.01, 1.08) 1.01 (0.97, 1.05) 1.05 (1.02, 1.09)
7 - 12 1.02 (0.99, 1.06) 0.99 (0.95, 1.04) 1.02 (0.98, 1.06)
≥ 13 1 1 1
Drug-related conviction ever† 0.98 (0.96, 1.00) 0.97 (0.95, 1.00) 0.98 (0.96, 1.01)
Sex-related conviction ever† 0.97 (0.92, 1.03) 0.96 (0.91, 1.01) 0.95 (0.89, 1.01)
Heroin use ever† 1.12 (1.05, 1.19) 1.15 (1.07, 1.24) 1.10 (1.03, 1.18)
Cocaine or crack use ever† 1.10 (1.08, 1.13) 1.16 (1.13, 1.19) 1.10 (1.08, 1.13)
Conventional HIV risk behavior‡ 1.10 (1.07, 1.13) 1.13 (1.10, 1.17) 1.07 (1.03, 1.10)
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Table 5.5 Comparison of complete case, multiple imputation, and restricted population covariate-adjusted 
analyses of HIV testing among adult males admitted to the North Carolina Department of Corrections, 
January 2004 - May 2006\ (cont.)
Complete Case Multiple Imputation Restricted population\
RR (95% CI) RR (95% CI) RR (95% CI)
Mental health§
Axis I 0.99 (0.93, 1.06) 1.04 (0.97, 1.11) 0.99 (0.92, 1.06)
Axis II 1.05 (0.99, 1.12) 1.04 (0.97, 1.12) 1.04 (0.97, 1.10)
Neither 1 1 1
Syphilis
Positive 1.00 (0.95, 1.05) 0.83 (0.79, 0.89) 0.99 (0.94, 1.04)
Negative 1 1 1
Tuberculosis 
Positive 1.21 (1.16, 1.26) 1.27 (1.20, 1.35) 1.21 (1.15, 1.27)
Negative 1 1 1
*model includes variable for intake facilities and covariates with reported estimates
†referent: never
‡includes same-sex sexual partner (men only), multiple sexual partners, prostitution, needle sharing, 
sex with MSM (women only), sex with injection drug user (women only), blood transfusion 1978-1985
§Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, 
and dementia; Axis II: personality disorder, developmental disability 
\complete case: N =31232, multiple imputation: N=47212, restricted N=20695
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Table 6.5. Estimated number of HIV cases among male prisoners who declined HIV testing 
Age NC DOC population                Estimated cases - NC DOC
Not Tested                  HIV-positive 
(Ni) Tested HIV+ Pi               95% CI* Vi* Nest Vc CIL CIU
Black 18-24 6025 1098 19 1.73 1.04 2.69 0.4898 104.23 870.0922
25-34 6189 2592 103 3.97 3.25 4.80 0.4235 245.70 680.6683
35-44 4349 2513 206 8.2 7.15 9.34 0.5816 356.62 642.7989
45-49 1328 851 82 9.64 7.74 11.82 1.1122 128.02 219.0280
50+ 1058 627 53 8.45 6.40 10.91 1.2551 89.40 175.9086
Other 18-24 738 138 3 2.17 0.45 6.22 2.0663 16.01 232.0978
25-34 999 356 14 3.93 2.17 6.51 1.3163 39.26 172.5789
35-44 390 178 10 5.62 2.73 10.09 2.2806 21.92 79.1817
45-49 97 36 2 5.56 0.68 18.66 6.6837 5.39 42.0599
50+ 61 23 1 4.35 0.11 21.95 8.9796 2.65 30.0110
White 18-24 3157 1094 2 0.18 0.02 0.66 0.2449 5.68 59.0758
25-34 3391 2720 26 0.96 0.62 1.40 0.2245 32.55 59.0391
35-44 2814 2226 31 1.39 0.95 1.97 0.2959 39.11 68.7133
45-49 870 666 9 1.35 0.62 2.55 0.6122 11.75 28.3081
50+ 775 343 1 0.29 0.01 1.61 0.6735 2.25 27.1783
Total 1100.6 3386.7 1229.6 5543.8
*based on exact confidence intervals
Pi = HIV+ / Tested
Nest  = PiNi
Vc = Ni
2Vi
(CIL, CIU) = ∑Nest  -/+  1.96* sqrt (∑Vc)
Table 6.5. Estimated number of HIV cases among male prisoners who declined HIV testing (continued)
Age NC population                   Estimated cases- state
Not Tested                  HIV-positive            
(Ni) Census pop† HIV+† Pi               95% CI‡ Vi‡ Nest Vc CIL CIU
Black 18-24 6025 610,266 1503 0.246 0.23 0.26 0.0063 14.84 0.1456
25-34 6189 774,821 7190 0.928 0.91 0.95 0.0109 57.43 0.4542
35-44 4349 781,696 16248 2.079 2.05 2.11 0.0161 90.40 0.4930
45-49 1328 358,335 6943 1.938 1.89 1.98 0.0230 25.73 0.0935
50+ 1058 1,022,745 7799 0.763 0.75 0.78 0.0086 8.07 0.0083
Other 18-24 738 97,820 137 0.140 0.12 0.16 0.0120 1.03 0.0078
25-34 999 150,305 1043 0.694 0.65 0.74 0.0214 6.93 0.0458
35-44 390 124,243 1116 0.898 0.85 0.95 0.0268 3.50 0.0109
45-49 97 48,474 297 0.613 0.54 0.68 0.0355 0.59 0.0012
50+ 61 123,214 380 0.308 0.28 0.34 0.0158 0.19 0.0001
White 18-24 3157 1,878,849 351 0.019 0.02 0.02 0.0010 0.59 0.0010
25-34 3391 2,845,195 3314 0.116 0.11 0.12 0.0020 3.95 0.0046
35-44 2814 2,943,125 7513 0.255 0.25 0.26 0.0029 7.18 0.0068
45-49 870 1,361,720 2711 0.199 0.19 0.21 0.0038 1.73 0.0011
50+ 775 5,203,678 2969 0.057 0.06 0.06 0.0010 0.44 0.0001
Total 222.6 1.3 220.4 224.8
†data pooled from 2000-2005; HIV+: number of living cases at mid-year
Pi = (HIV+) / Census
Nest  = PiNi
Vc = Ni
2Vi
(CIL, CIU) = ∑Nest  -/+  1.96* sqrt (∑Vc)
‡ based on asymptotic confidence intervals
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